Zahinoor Ismail
Associate Professor (E&R)
Z.Ismail@exeter.ac.uk
Publications
Journal articles
Creese B (In Press). A Data-Driven Examination of Apathy and Depressive Symptoms in Dementia with Independent Replication. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
Creese B (In Press). A longitudinal study of late-life psychosis and incident dementia and the potential effects of race and cognition. Nature Mental Health
Ballard C, Brooker H, Corbett A, Ismail Z, Creese B, Wesnes K (In Press). FLAME: a computerized neuropsychological composite for trials in early dementia. Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring
Wolfova K, Creese B, Aarsland D, Ismail Z, Corbett A, Ballard C, Hampshire A, Cermakova P (In Press). Gender/sex differences in the association of mild behavioral impairment with cognitive aging. Journal of Alzheimer's Disease
Creese B, Arathimos R, Brooker H, Aarsland D, Corbett A, Lewis C, Ballard C, Ismail Z (In Press). Genetic risk for Alzheimer’s disease, cognition and Mild Behavioral Impairment in healthy older adults. Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring
Creese B, Arathimos R, Aarsland D, Ballard C, Brooker H, Hampshire A, Corbett A, Ismail Z (In Press). Late-life onset psychotic symptoms and incident cognitive impairment in people without dementia: modification by genetic risk for Alzheimer’s disease. Alzheimer's and Dementia: Translational Research and Clinical Interventions
Creese BA, Brooker H, Ismail Z, Wesnes K, Adam H, Khan Z, Maria M, Corbett A, Aarsland D, Ballard C, et al (In Press). Mild Behavioral Impairment as a Marker of Cognitive Decline in Cognitively Normal Older Adults. American Journal of Geriatric Psychiatry
Creese B, Ismail Z (In Press). Mild Behavioral Impairment: measurement and clinical correlates of a novel marker of preclinical Alzheimer’s disease. Alzheimer's Research and Therapy Abstract.
Creese B, Ballard C (In Press). Revisiting criteria for psychosis in Alzheimer’s disease and related dementias- towards better phenotypic classification and biomarker research. Journal of Alzheimer's Disease
Souza R, Stanley EAM, Camacho M, Camicioli R, Monchi O, Ismail Z, Wilms M, Forkert ND (2024). A multi-center distributed learning approach for Parkinson's disease classification using the traveling model paradigm. Frontiers in Artificial Intelligence, 7
Therrien F, Ward C, Chokka P, Habert J, Ismail Z, McIntyre RS, MacKenzie EM (2024). Adjunctive Brexpiprazole for Patient Life Engagement in Major Depressive Disorder: a Canadian, Phase 4, Open-Label, Interventional Study: Brexpiprazole d'appoint pour l'engagement dans la vie des patients souffrant de trouble dépressif majeur: une étude interventionnelle canadienne ouverte de phase 4. The Canadian Journal of Psychiatry Abstract.
Wong B, Ismail Z, Watt J, Holroyd-Leduc J, Goodarzi Z (2024). Barriers and facilitators to care for agitation and/or aggression among persons living with dementia in long-term care. BMC Geriatr, 24(1). Abstract. Author URL.
Chen APF, Ismail Z, Mann FD, Bromet EJ, Clouston SAP, Luft BJ (2024). Behavioral Impairments and Increased Risk of Cortical Atrophy Risk Scores Among World Trade Center Responders. J Geriatr Psychiatry Neurol, 37(2), 114-124. Abstract. Author URL.
Lam RW, Kennedy SH, Adams C, Bahji A, Beaulieu S, Bhat V, Blier P, Blumberger DM, Brietzke E, Chakrabarty T, et al (2024). Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 Update on Clinical Guidelines for Management of Major Depressive Disorder in Adults: Réseau canadien pour les traitements de l'humeur et de l'anxiété (CANMAT) 2023 : Mise à jour des lignes directrices cliniques pour la prise en charge du trouble dépressif majeur chez les adultes. Can J Psychiatry Abstract. Author URL.
Ismail Z, Black SE, Smith EE, Muir RT (2024). Comparative methods for quantifying plasma biomarkers in Alzheimer's disease: Implications for the next frontier in cerebral amyloid angiopathy diagnostics. Alzheimer's and Dementia, 20(2), 1436-1458. Abstract.
Camacho M, Wilms M, Almgren H, Amador K, Camicioli R, Ismail Z, Monchi O, Forkert ND, Alzheimer’s Disease Neuroimaging Initiative (2024). Exploiting macro- and micro-structural brain changes for improved Parkinson's disease classification from MRI data. NPJ Parkinsons Dis, 10(1). Abstract. Author URL.
Watt JA, Porter J, Tavilsup P, Chowdhury M, Hatch S, Ismail Z, Kumar S, Kirkham J, Goodarzi Z, Seitz D, et al (2024). Guideline Recommendations on Behavioral and Psychological Symptoms of Dementia: a Systematic Review. J Am Med Dir Assoc, 25(5), 837-846.e21. Abstract. Author URL.
Rouse HJ, Ismail Z, Andel R, Molinari VA, Schinka JA, Small BJ (2024). Impact of Mild Behavioral Impairment on Longitudinal Changes in Cognition. J Gerontol a Biol Sci Med Sci, 79(1). Abstract. Author URL.
Matuskova V, Veverova K, Jester DJ, Matoska V, Ismail Z, Sheardova K, Horakova H, Cerman J, Laczó J, Andel R, et al (2024). Mild behavioral impairment in early Alzheimer's disease and its association with APOE and BDNF risk genetic polymorphisms. Alzheimers Res Ther, 16(1). Abstract. Author URL.
Matuskova V, Veverova K, Jester D, Matoska V, Ismail Z, Sheardova K, Horakova H, Laczó J, Hort J, Vyhnalek M, et al (2024). Mild behavioral impairment in prodromal Alzheimer´s disease and its association with APOE and BDNF risk genetic polymorphisms. International Psychogeriatrics, 35(S1), 26-27.
Soto M, Rosenberg P, Ballard C, Vellas B, Miller D, Gauthier S, Carrillo MC, Lyketsos C, Ismail Z, Abushakra S, et al (2024). Neuropsychiatric Symptoms in AD: Clinical Trials Targeting Mild Behavioral Impairment: a Report from the International CTAD Task Force. JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE, 11(1), 56-64. Author URL.
Rashidi-Ranjbar N, Churchill NW, Black SE, Kumar S, Tartaglia MC, Freedman M, Lang A, Steeves TDL, Swartz RH, Saposnik G, et al (2024). Neuropsychiatric symptoms and brain morphology in patients with mild cognitive impairment, cerebrovascular disease and Parkinson disease: a cross sectional and longitudinal study. Int J Geriatr Psychiatry, 39(3). Abstract. Author URL.
Colijn MA, Ismail Z (2024). Presenilin Gene Mutation-associated Psychosis: Phenotypic Characteristics and Clinical Implications. Alzheimer Dis Assoc Disord, 38(1), 101-106. Abstract. Author URL.
Cummings J, Sano M, Auer S, Bergh S, Fischer CE, Gerritsen D, Grossberg G, Ismail Z, Lanctôt K, Lapid MI, et al (2024). Reduction and prevention of agitation in persons with neurocognitive disorders: an international psychogeriatric association consensus algorithm. Int Psychogeriatr, 36(4), 251-262. Abstract. Author URL.
Matsuoka T, Ismail Z, Imai A, Shibata K, Nakamura K, Nishimura Y, Rubinstein E, Uchida H, Mimura M, Narumoto J, et al (2024). Relationship between Loneliness and Mild Behavioral Impairment: Validation of the Japanese Version of the MBI Checklist and a Cross-Sectional Study. J Alzheimers Dis, 97(4), 1951-1960. Abstract. Author URL.
Naude J, Wang M, Leon R, Smith E, Ismail Z (2024). Tau-PET in early cortical Alzheimer brain regions in relation to mild behavioral impairment in older adults with either normal cognition or mild cognitive impairment. Neurobiology of Aging, 138, 19-27.
Mallo SC, Creese B, Real-Deus E, Ismail Z, Pereiro AX, Juncos-Rabadán O (2024). The assessment of Mild Behavioral Impairment (MBI): Some methodological issues. International Psychogeriatrics, 35(S1), 25-26.
Atchison K, Toohey AM, Ismail Z, Goodarzi Z (2024). Understanding the Barriers to and Facilitators of Anxiety Management in Residents of Long-Term Care. Can J Aging, 43(1), 57-74. Abstract. Author URL.
Monchi O, Pinilla-Monsalve GD, Almgren H, Ghahremani M, Kibreab M, Maarouf N, Kathol I, Boré A, Rheault F, Descoteaux M, et al (2024). White Matter Microstructural Underpinnings of Mild Behavioral Impairment in Parkinson's Disease. Mov Disord Abstract. Author URL.
Ismail Z, Leon R, Chen H, Robert P, Smith EE (2023). A longitudinal multimodal biomarker study of memory clinic MCI patients with MBI – are there links to Alzheimer disease?. Alzheimer's & Dementia, 19(S14).
Sano M, Cummings J, Auer S, Bergh S, Fischer CE, Gerritsen D, Grossberg G, Ismail Z, Lanctôt K, Lapid MI, et al (2023). Agitation in cognitive disorders: Progress in the International Psychogeriatric Association consensus clinical and research definition. International psychogeriatrics, 36(4), 238-250. Abstract.
Ismail Z, Aarsland D, Ballard CG, Corbett A, Creese B (2023). Assessing risk taking and decision making associated with late‐life onset mild psychotics symptoms in cognitively normal older adults. Alzheimer's & Dementia, 19(S18).
Thase ME, Ismail Z, Meehan SR, Weiss C, Regnier SA, Larsen KG, McIntyre RS (2023). Assessment of patient life engagement in major depressive disorder using items from the Inventory of Depressive Symptomatology Self-Report (IDS-SR). Journal of Psychiatric Research, 161, 132-139.
Mallo SC, Fernández MÁR, Vázquez‐Vázquez L, Galdo‐Álvarez S, Lindín M, Nieto‐Vieites A, Juncos‐Rabadán O, Aldrey JM, Díaz F, Ismail Z, et al (2023). Association between Mild Behavioral Impairment trajectories and AD biomarkers in adults with Mild Cognitive Impairment. Results from the CompAS study. Alzheimer's & Dementia, 19(S14).
Housni I, Singh M, Dadar M, Detcheverry F, Anastassiadis C, Filali‐Mouhim A, Masellis M, Ismail Z, Duchesne S, Tartaglia C, et al (2023). Associations of white matter hyperintensities with cerebrovascular architecture in Alzheimer’s disease and related dementias. Alzheimer's & Dementia, 19(S17).
Sharif SF, Guan DX, Ghahremani M, Leon R, Smith EE, Ismail Z (2023). Biomarkers of synaptic and neuronal dysfunction in relation to mild behavioral impairment: a study of dementia‐free older adults. Alzheimer's & Dementia, 19(S18).
Angioni D, Hansson O, Bateman RJ, Rabe C, Toloue M, Braunstein JB, Agus S, Sims JR, Bittner T, Carrillo MC, et al (2023). Can We Use Blood Biomarkers as Entry Criteria and for Monitoring Drug Treatment Effects in Clinical Trials? a Report from the EU/US CTAD Task Force. Journal of Prevention of Alzheimer's Disease, 10(3), 418-425. Abstract.
Andruchow D, Cunningham D, Sharma MJ, Ismail Z, Callahan BL (2023). Characterizing mild cognitive impairment to predict incident dementia in adults with bipolar disorder: What should the benchmark be?. Clin Neuropsychol, 37(7), 1455-1478. Abstract. Author URL.
Matuskova V, Krejci M, Horakova H, Ismail Z, Laczó J, Hort J, Vyhnalek M (2023). Comparison between self‐ and informant‐rated versions of the Mild behavioral impairment checklist in patients with mild cognitive impairment. Alzheimer's & Dementia, 19(S18).
Wu Y, Levis B, Daray FM, Ioannidis JPA, Patten SB, Cuijpers P, Ziegelstein RC, Gilbody S, Fischer FH, Fan S, et al (2023). Comparison of the accuracy of the 7-item HADS Depression subscale and 14-item total HADS for screening for major depression: a systematic review and individual participant data meta-analysis. Psychol Assess, 35(2), 95-114. Abstract. Author URL.
Therrien F, Ward C, Zhang Z, Chokka P, Habert J, Ismail Z, McIntyre RS, MacKenzie E (2023). Correlations between patient life engagement and other outcomes in a phase 4 study of adjunctive brexpiprazole for major depressive disorder. Neuroscience Applied, 2
Vellone DA, Ismail Z (2023). Cross‐Sectional and Longitudinal Associations of Mild Behavioural Impairment‐Apathy and Alzheimer’s Disease‐Related Biomarkers. Alzheimer's & Dementia, 19(S24).
Moore JA, Tuladhar A, Ismail Z, Mouches P, Wilms M, Forkert ND (2023). Dementia in Convolutional Neural Networks: Using Deep Learning Models to Simulate Neurodegeneration of the Visual System. NEUROINFORMATICS, 21(1), 45-55. Author URL.
Lanctôt KL, Ismail Z, Bawa KK, Cummings JL, Husain M, Mortby ME, Robert P (2023). Distinguishing apathy from depression: a review differentiating the behavioral, neuroanatomic, and treatment‐related aspects of apathy from depression in neurocognitive disorders. International Journal of Geriatric Psychiatry, 38(2).
Choudhury S, Leventhal N, Soffer M, Zarei S, Burhan AM, Colman S, Chu L, Davies S, Derkach P, Elmi S, et al (2023). Effect of agitation and aggression on quality of life in patients with dementia. Alzheimer's & Dementia, 19(S5).
McIntyre RS, Therrien F, Ismail Z, Meehan SR, Miguelez M, Larsen KG, Chen D, MacKenzie EM, Thase ME (2023). Effects of adjunctive brexpiprazole on patient life engagement in major depressive disorder: Post hoc analysis of Inventory of Depressive Symptomatology Self-Report data. Journal of Psychiatric Research, 162, 71-78.
MacKenzie E, Ward C, Zhang Z, Chokka P, Habert J, Ismail Z, McIntyre RS, Therrien F (2023). Effects of adjunctive brexpiprazole on patient-reported efficacy measures in major depressive disorder: a phase 4, open-label, interventional study. Neuroscience Applied, 2
Ebrahim IM, Ghahremani M, Camicioli R, Smith EE, Ismail Z (2023). Effects of race, baseline cognition, and APOE on the association of affective dysregulation with incident dementia: a longitudinal study of dementia-free older adults. J Affect Disord, 332, 9-18. Abstract. Author URL.
Goodarzi Z, Holroyd-Leduc J, Seitz D, Ismail Z, Kirkham J, Wu P, Fox L, Hykaway W, Grossman L, Ewa V, et al (2023). Efficacy of virtual interventions for reducing symptoms of depression in community-dwelling older adults: a systematic review. Int Psychogeriatr, 35(3), 131-141. Abstract. Author URL.
Wang M, Chekouo T, Ismail Z, Forkert ND, Hogan DB, Ganesh A, Camicioli R, Seitz D, Borrie MJ, Hsiung G-YR, et al (2023). Elicited clinician knowledge did not improve dementia risk prediction in individuals with mild cognitive impairment. Journal of Clinical Epidemiology, 158, 111-118.
Namasivayam A, Gupta A, Dissanayake AS, Khoury M, Bowie CR, Butters MA, Flint AJ, Gallagher D, Golas AC, Herrmann N, et al (2023). Examining the sex-specific association between APOE ε4 status and increased neuropsychiatric symptom burden in populations at risk for Alzheimer's disease. American Journal of Geriatric Psychiatry, 31(10), e6-e7.
Tavilsup P, Abolarin M, Jakubec S, Roach P, Smith EE, Goodarzi Z, Kirkham J, Ismail Z, Svrcek C, Seitz D, et al (2023). Experiences of People Living with Dementia and their Care Partners in Participating in Outdoor Activities. Alzheimer's & Dementia, 19(S20).
Wang M, Sajobi TT, Hogan DB, Ganesh A, Seitz DP, Chekouo T, Forkert ND, Borrie MJ, Camicioli R, Hsiung G-YR, et al (2023). Expert elicitation of risk factors for progression to dementia in individuals with mild cognitive impairment. Alzheimers Dement, 19(10), 4542-4548. Abstract. Author URL.
Camacho M, Wilms M, Mouches P, Almgren H, Souza R, Camicioli R, Ismail Z, Monchi O, Forkert ND (2023). Explainable classification of Parkinson’s disease using deep learning trained on a large multi-center database of T1-weighted MRI datasets. NeuroImage: Clinical, 38, 103405-103405.
Jaworska N, Krewulak KD, Schalm E, Niven DJ, Ismail Z, Burry LD, Leigh JP, Fiest KM (2023). Facilitators and Barriers Influencing Antipsychotic Medication Prescribing and Deprescribing Practices in Critically Ill Adult Patients: a Qualitative Study. Journal of General Internal Medicine, 38(10), 2262-2271. Abstract.
Isaza JCU, Guan DX, Ismail Z (2023). Frailty and mild behavioral impairment: a longitudinal study of pre‐dementia markers. Alzheimer's & Dementia, 19(S23).
Ghahremani M, Nathan S, Smith EE, McGirr A, Goodyear B, Ismail Z (2023). Functional connectivity and mild behavioral impairment in dementia‐free elderly. Alzheimer's & Dementia: Translational Research & Clinical Interventions, 9(1).
Guan DX, Rehman T, Nathan S, Durrani R, Potvin O, Duchesne S, Pike GB, Smith EE, Ismail Z (2023). Further along the Alzheimer’s disease continuum: associations between mild behavioral impairment with hippocampal and entorhinal volume and incident cognitive decline. Alzheimer's & Dementia, 19(S18).
Ghahremani M, Ismail Z (2023). Grumpy old men: agitation, aggression, and impulsivity in older adults and risk of incident dementia. Alzheimer's & Dementia, 19(S18).
Frank A, Ismail Z, Wilson M, Gauthier S, Verret L, Hsiung G-YR, Borrie M (2023). Health System Change for Alzheimer's Disease-Modifying Therapies in Canada: Beginning the Discussion. Can J Neurol Sci, 1-9. Abstract. Author URL.
Wang M, Sajobi T, Ganesh A, Seitz D, Chekouo T, Forkert ND, Borrie M, Camicioli R, Hsiung GR, Masellis M, et al (2023). Identifying prognostic factors of dementia in individuals with mild cognitive impairment (MCI): Are statistical models adequate?. Alzheimer's & Dementia, 19(S8).
Ghahremani M, Smith EE, Ismail Z (2023). Improving dementia prognostication in cognitively normal older adults: conventional versus novel approaches to modelling risk associated with neuropsychiatric symptoms. Alzheimer's & Dementia, 19(S18).
Munir A, Ghahremani M, Smith EE, Creese B, Fischer CE, Ismail Z (2023). Late life onset of persistent psychosis and incident dementia: risk stratification by baseline cognitive status. Alzheimer's & Dementia, 19(S4).
Creese B, Gibbs O, Moodie E, Hampshire A, Corbett A, Ismail Z (2023). Late-life Onset Psychosis-like Symptoms Assessed in the Mild Behavioral Impairment Framework are Associated Impaired Performance on the Stroop Task. In&Vertebrates
Rojas-Rozo L, Lee L, Khanassov V, Sivananthan S, Ismail Z, Gauthier S, Vedel I (2023). Latest Canadian Consensus Conference on the Diagnosis and Treatment of Dementia: What's in it for Primary Care?. Can J Aging, 1-12. Abstract. Author URL.
Mudalige D, Guan DX, Ghahremani M, Ismail Z (2023). Longitudinal Associations Between Mild Behavioral Impairment, Sleep Disturbance, and Progression to Dementia. Journal of Alzheimer's Disease Reports, 7(1), 1323-1334. Abstract.
Ghahremani M, Chen H, Creese B, Goodarzi Z, Smith EE, Ismail Z (2023). Longitudinal association between exposure to vitamin D supplementation and incident dementia – a study of dementia‐free older adults. Alzheimer's & Dementia, 19(S8).
Mudalige DM, Guan DX, Ghahremani M, Ismail Z (2023). Longitudinal associations between mild behavioral impairment, sleep disturbance, and progression to dementia. Alzheimer's & Dementia, 19(S18).
Ebrahim I, Ghahremani M, Smith EE, Camicioli R, Ismail Z (2023). Longitudinal associations of emergent and persistent affective dysregulation symptoms with incident dementia in dementia‐free older adults. Alzheimer's & Dementia, 19(S4).
Vellone DA, Ghahremani M, Ismail Z (2023). MBI‐apathy, ApoEɛ2, and risk for Alzheimer disease dementia. Alzheimer's & Dementia, 19(S4).
Almgren H, Camacho M, Hanganu A, Kibreab M, Camicioli R, Ismail Z, Forkert ND, Monchi O (2023). Machine learning-based prediction of longitudinal cognitive decline in early Parkinson's disease using multimodal features. Sci Rep, 13(1). Abstract. Author URL.
Bawa KK, Sankhe K, Bateman D, Cummings JL, Ereshefsky L, Husain M, Ismail Z, Manera V, Mintzer J, Moebius HJ, et al (2023). Mapping of validated apathy scales onto the apathy diagnostic criteria for neurocognitive disorders. Alzheimer's & Dementia, 19(S18).
Durrani R, Wang M, Cox E, Irving E, Saad F, McCreary CR, Beaudin AE, Gee M, Nelles K, Sajobi TT, et al (2023). Mediators of cognitive impairment in cerebral amyloid angiopathy. Int J Stroke, 18(1), 78-84. Abstract. Author URL.
Elefante C, Brancati GE, Ismail Z, Ricciardulli S, Beatino MF, Lepri V, Famà A, Ferrari E, Giampietri L, Baldacci F, et al (2023). Mild Behavioral Impairment in Psychogeriatric Patients: Clinical Features and Psychopathology Severity. J Clin Med, 12(16). Abstract. Author URL.
Guan DX, Rehman T, Nathan S, Durrani R, Smith EE, Ismail Z (2023). Mild behavioral impairment as an indicator of early dementia neurodegeneration: Evidence from structural neuroimaging. Alzheimer's & Dementia, 19(S4).
Dibbern P, Horsch J, Fiegl J, Eckl L, Finger T, Diermeier L, Deppe M, Schiekofer S, Langguth B, Ismail Z, et al (2023). Mild behavioral impairment checklist: English-German translation and feasibility study assessing its use in clinical practice. Zeitschrift fur Gerontologie und Geriatrie Abstract.
Almgren H, Hanganu A, Camacho M, Kibreab M, Camicioli R, Ismail Z, Forkert ND, Monchi O (2023). Motor symptoms in Parkinson's disease are related to the interplay between cortical curvature and thickness. Neuroimage Clin, 37 Abstract. Author URL.
Rashidi‐Ranjbar N, Churchill NW, Black SE, Kumar S, Tartaglia C, Freedman M, Lang AE, Steeves T, Swartz RH, Saposnik G, et al (2023). Neural Correlates of Mild Behavioral Impairment in older adults across the neurodegenerative spectrum. Alzheimer's & Dementia, 19(S18).
Karamazovova S, Matuskova V, Ismail Z, Vyhnalek M (2023). Neuropsychiatric symptoms in spinocerebellar ataxias and Friedreich ataxia. Neurosci Biobehav Rev, 150 Abstract. Author URL.
Ismail Z, Leon R, Creese B, Ballard C, Robert P, Smith EE (2023). Optimizing detection of Alzheimer’s disease in mild cognitive impairment: a 4-year biomarker study of mild behavioral impairment in ADNI and MEMENTO. Molecular Neurodegeneration, 18(1). Abstract.
Lam K, Wang M, Smith E, Ismail Z, Ganesh A (2023). P.004 Comparison of the Montreal Cognitive Assessment (MoCA) and Rowland Universal Dementia Assessment Scale (RUDAS) for identification of mild cognitive impairment and dementia. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, 50(s2), s58-s58.
O’Connell M, Camicioli R, Cammer A, Chertkow H, Desmarais P, Fisk J, Freedman M, Friedman N, Geddes M, Ismail Z, et al (2023). P.005 a virtual interdisciplinary diagnostic memory clinic: rural patient and caregiver satisfaction. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, 50(s2), s58-s58.
Lam K, Wang M, Smith E, Ismail Z, Ganesh A (2023). P.009 Comparison of Montreal Cognitive Assessment (MoCA) and Rowland Universal Dementia Assessment Scale (RUDAS) scores in diverse populations. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, 50(s2), s59-s60.
Guan DX, Smith EE, Pike GB, Ismail Z (2023). Persistence of neuropsychiatric symptoms and dementia prognostication: a comparison of three operational case definitions of mild behavioral impairment. Alzheimers Dement (Amst), 15(4). Abstract. Author URL.
Ghahremani M, Wang M, Chen H-Y, Zetterberg H, Smith E, Ismail Z, Alzheimer's Disease Neuroimaging Initiative* (2023). Plasma Phosphorylated Tau at Threonine 181 and Neuropsychiatric Symptoms in Preclinical and Prodromal Alzheimer Disease. Neurology, 100(7), e683-e693. Abstract. Author URL.
Pépin É, Tanguay N, Roy M-P, Macoir J, Bruneau M-A, Ismail Z, Hudon C (2023). Preliminary Validation Study of the French-Quebec Version of the Mild Behavioral Impairment Checklist. Cogn Behav Neurol, 36(1), 9-18. Abstract. Author URL.
Lin RSY, Yu DSF, Chau PH, Li PWC, Ismail Z (2023). Reliability and Validity of the Traditional Chinese Version of the Mild Behavioral Impairment – Checklist Among Persons with Mild Cognitive Impairment – a Validation Study. Journal of Geriatric Psychiatry and Neurology, 36(1), 26-38. Abstract.
Mortby ME, Ismail Z, Kiely KM, Fischer CE, Anstey KJ (2023). Risk of Mild Behavioral Impairment: the role of gender and APOE allele carrier status. Alzheimer's & Dementia, 19(S18).
Choudhury S, Colman S, Chu L, Davies S, Derkach P, Elmi S, Fischer CE, Gerretsen P, Graff‐Guerrero A, Hussain M, et al (2023). Sex Differences in Behavioral and Psychological Symptoms in Institutionalized Patients with Advanced Alzheimer’s Disease. Alzheimer's & Dementia, 19(S18).
Guan DX, Rockwood K, Smith EE, Ismail Z (2023). Sex as a moderator of the association between frailty and mild behavioral impairment. Alzheimer's & Dementia, 19(S4).
Mudalige DM, Ebrahim I, Guan DX, Goodarzi Z, Ismail Z (2023). Sex differences in the prevalence of mild behavioral impairment: a systematic review and meta‐analysis. Alzheimer's & Dementia, 19(S4).
Mudalige DM, Goodarzi Z, Ebrahim I, Guan DX, Ismail Z (2023). Sex prevalence in mild behavioral impairment: a systematic review and meta‐analysis. Alzheimer's & Dementia, 19(S18).
Khoury MA, Valcic M, Churchill NW, Fornazzari LR, Mortby ME, Ismail Z, De Luca V, Munoz DG, Schweizer TA, Fischer CE, et al (2023). Sex‐specific neuropsychiatric burden distinguished by APOE4 status and cortical thickness. Alzheimer's & Dementia, 19(S14).
Moore JA, Wilms M, Gutierrez A, Ismail Z, Fakhar K, Hadaeghi F, Hilgetag CC, Forkert ND (2023). Simulation of neuroplasticity in a CNN-based in-silico model of neurodegeneration of the visual system. Frontiers in Computational Neuroscience, 17
Chen C-H, Khnaijer MK, Beaudin AE, McCreary CR, Gee M, Saad F, Frayne R, Ismail Z, Pike GB, Camicioli R, et al (2023). Subcortical volumes in cerebral amyloid angiopathy compared with Alzheimer's disease and controls. FRONTIERS IN NEUROSCIENCE, 17 Author URL.
Khoury MA, Bahsoun M, Fahdel A, Shunbuli S, Venkatesh S, Ghazvanchachi A, Mitha S, Chan K, Fornazzari LR, Churchill NW, et al (2023). Tau influences the severity of delusions in older persons with early‐stage cognitive decline. Alzheimer's & Dementia, 19(S2).
Gosselin P, Guan DX, Smith EE, Ismail Z (2023). Temporal associations between treated and untreated hearing loss and mild behavioral impairment in older adults without dementia. Alzheimer's & Dementia, 19(S23).
Gosselin P, Guan DX, Smith EE, Ismail Z (2023). Temporal associations between treated and untreated hearing loss and mild behavioral impairment in older adults without dementia. Alzheimers Dement (N Y), 9(4). Abstract. Author URL.
Guan DX, Mudalige DM, Munro CE, Nosheny RL, Smith EE, Ismail Z (2023). The effect of study partner characteristics on the reporting of neuropsychiatric symptoms in older adults with and without dementia. Alzheimer's & Dementia, 19(S18).
Elefante C, Brancati GE, Pistolesi G, Amadori S, Torrigiani S, Baldacci F, Ceravolo R, Ismail Z, Lattanzi L, Perugi G, et al (2023). The impact of mild behavioral impairment on the prognosis of geriatric depression: preliminary results. Int Clin Psychopharmacol Abstract. Author URL.
Mallo SC, Real‐Deus E, Nieto‐Vieites A, Felpete A, Lojo‐Seoane C, Pérez‐Blanco L, Ismail Z, Pereiro AX (2023). Underlying structure of the MBI‐C in pre‐symptomatic and prodromic states of dementia: a multidimensional scaling approach. Alzheimer's & Dementia, 19(S4).
Hu S, Patten S, Charlton A, Fischer K, Fick G, Smith EE, Ismail Z (2023). Validating the Mild Behavioral Impairment Checklist in a Cognitive Clinic: Comparisons with the Neuropsychiatric Inventory Questionnaire. JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY, 36(2), 107-120. Author URL.
Gauthier S, Ismail Z, Goodarzi Z, Ng KP, Rosa-Neto P (2023). Viewpoint: Clinicians' Perspectives on How Disease Modifying Drugs for Alzheimer's Disease Impact Specialty Care. J Prev Alzheimers Dis, 10(3), 339-341. Abstract. Author URL.
Ghahremani M, Smith EE, Chen H-Y, Creese B, Goodarzi Z, Ismail Z (2023). Vitamin D supplementation and incident dementia: Effects of sex, APOE, and baseline cognitive status. Alzheimers Dement (Amst), 15(1). Abstract. Author URL.
Jaworska N, Makuk K, Krewulak KD, Niven DJ, Ismail Z, Burry LD, Mehta S, Fiest KM (2022). A National Modified Delphi Consensus Process to Prioritize Experiences and Interventions for Antipsychotic Medication Deprescribing Among Adult Patients with Critical Illness. Critical Care Explorations, 4(12).
Wang M, Sajobi TT, Ismail Z, Seitz D, Chekouo T, Forkert ND, Fischer K, Mackie A, Pearson D, Patry D, et al (2022). A pragmatic dementia risk score for patients with mild cognitive impairment in a memory clinic population: Development and validation of a dementia risk score using routinely collected data. Alzheimer's & Dementia: Translational Research & Clinical Interventions, 8(1).
Jaworska N, Moss SJ, Krewulak KD, Stelfox Z, Niven DJ, Ismail Z, Burry LD, Fiest KM (2022). A scoping review of perceptions from healthcare professionals on antipsychotic prescribing practices in acute care settings. BMC Health Serv Res, 22(1). Abstract. Author URL.
Jaworska N, Moss SJ, Krewulak KD, Stelfox Z, Niven D, Ismail Z, Burry L, Fiest K (2022). Antipsychotic prescribing practices and patient, family member and healthcare professional perceptions of antipsychotic prescribing in acute care settings: a scoping review protocol. BMJ Open, 12(6). Abstract.
Vellone D, Ghahremani M, Goodarzi Z, Forkert ND, Smith EE, Ismail Z (2022). Apathy and APOE in mild behavioral impairment, and risk for incident dementia. Alzheimers Dement (N Y), 8(1). Abstract. Author URL.
Mortby ME, Adler L, Agüera-Ortiz L, Bateman DR, Brodaty H, Cantillon M, Geda YE, Ismail Z, Lanctôt KL, Marshall GA, et al (2022). Apathy as a Treatment Target in Alzheimer's Disease: Implications for Clinical Trials. Am J Geriatr Psychiatry, 30(2), 119-147. Abstract. Author URL.
Cassidy CM, Therriault J, Pascoal TA, Cheung V, Savard M, Tuominen L, Chamoun M, McCall A, Celebi S, Lussier F, et al (2022). Association of locus coeruleus integrity with Braak stage and neuropsychiatric symptom severity in Alzheimer's disease. Neuropsychopharmacology, 47(5), 1128-1136. Abstract. Author URL.
Ismail Z, Babulal GM (2022). Attitudinal adjustment about dementia awareness and assessment: finetuning inclusion, diversity, and measurement of behavioral and psychological symptoms. International Psychogeriatrics, 35(1), 7-10.
Herrmann N, Ismail Z, Collins R, Desmarais P, Goodarzi Z, Henri‐Bhargava A, Iaboni A, Kirkham J, Massoud F, Moser A, et al (2022). CCCDTD5 recommendations on the deprescribing of cognitive enhancers in dementia. Alzheimer's & Dementia: Translational Research & Clinical Interventions, 8(1).
Beaudin AE, McCreary CR, Mazerolle EL, Gee M, Sharma B, Subotic A, Zwiers AM, Cox E, Nelles K, Charlton A, et al (2022). Cerebrovascular Reactivity Across the Entire Brain in Cerebral Amyloid Angiopathy. Neurology, 98(17), e1716-e1728. Abstract. Author URL.
Kassam F, Chen H, Nosheny RL, McGirr A, Williams T, Ng N, Camacho M, Mackin RS, Weiner MW, Ismail Z, et al (2022). Cognitive profile of people with mild behavioral impairment in Brain Health Registry participants. International Psychogeriatrics, 35(11), 643-652. Abstract.
Valcic M, Khoury MA, Kim J, Fornazzari L, Churchill NW, Ismail Z, De Luca V, Tsuang D, Schweizer TA, Munoz DG, et al (2022). Correction: Valcic et al. Determining Whether Sex and Zygosity Modulates the Association between APOE4 and Psychosis in a Neuropathologically-Confirmed Alzheimer’s Disease Cohort. Brain Sci. 2022, 12, 1266. Brain Sciences, 13(1), 64-64. Abstract.
Saposnik G, Ismail Z, Rivard A-M, Knifton D, Bromfield G, Terzaghi M, Montoya A, Menard M-C (2022). Decision making under uncertainty in the diagnosis and management of Alzheimer's Disease in primary care: a study protocol applying concepts from neuroeconomics. Frontiers in Medicine, 9
Khoury MA, Bahsoun M-A, Fadhel A, Shunbuli S, Venkatesh S, Ghazvanchahi A, Mitha S, Chan K, Fornazzari LR, Churchill NW, et al (2022). Delusional Severity is Associated with Abnormal Texture in FLAIR MRI. Brain Sciences, 12(5), 600-600. Abstract.
Wang M, Greenberg M, Forkert ND, Chekouo T, Afriyie G, Ismail Z, Smith EE, Sajobi TT (2022). Dementia risk prediction in individuals with mild cognitive impairment: a comparison of Cox regression and machine learning models. BMC Med Res Methodol, 22(1). Abstract. Author URL.
Wong B, Ismail Z, Goodarzi Z (2022). Detecting depression in persons living with mild cognitive impairment: a systematic review. International Psychogeriatrics, 34(5), 453-465. Abstract.
Valcic M, Khoury MA, Kim J, Fornazzari L, Churchill NW, Ismail Z, De Luca V, Tsuang D, Schweizer TA, Munoz DG, et al (2022). Determining Whether Sex and Zygosity Modulates the Association between APOE4 and Psychosis in a Neuropathologically-Confirmed Alzheimer’s Disease Cohort. Brain Sciences, 12(9), 1266-1266. Abstract.
Black SAG, Stepanchuk AA, Templeton GW, Hernandez Y, Ota T, Roychoudhury S, Smith EE, Barber PA, Ismail Z, Fischer K, et al (2022). Diagnosing Alzheimer's Disease from Circulating Blood Leukocytes Using a Fluorescent Amyloid Probe. Journal of Alzheimer's Disease, 85(4), 1721-1734.
Guan DX, Chen H-Y, Camicioli R, Montero-Odasso M, Smith EE, Ismail Z (2022). Dual-task gait and mild behavioral impairment: the interface between non-cognitive dementia markers. Exp Gerontol, 162 Abstract. Author URL.
Bray MJC, Bryant BR, Esagoff AI, Richey LN, Rodriguez C, Krieg A, McCullough G, Tsai J, Tobolowsky W, Jahed S, et al (2022). Effect of traumatic brain injury on mild behavioral impairment domains prior to all‐cause dementia diagnosis and throughout disease progression. Alzheimer's & Dementia: Translational Research & Clinical Interventions, 8(1).
Sharma B, Gee M, Nelles K, Cox E, Irving E, Saad F, Yuan J, McCreary CR, Ismail Z, Camicioli R, et al (2022). Gait in Cerebral Amyloid Angiopathy. Journal of the American Heart Association, 11(19). Abstract.
Rouse HJ, Small BJ, Ismail Z (2022). Impact of Mild Behavioral Impairment and Mild Cognitive Impairment on Risk for Dementia. Alzheimer's & Dementia, 18(S7).
Choudhury S, Ghodasara S, Stiffel M, Fischer CE, Tang-Wai DF, Smith EE, Massoud F, Robin Hsiung G-Y, Lee L, Bruneau M-A, et al (2022). Informant-based tools for assessment and monitoring of cognition, behavior, and function in neurocognitive disorders: Systematic review and report from a CCCDTD5 Working Group. Int J Geriatr Psychiatry, 37(2). Abstract. Author URL.
Rojas-Rozo L, Vedel I, Sivananthan S, Ismail Z, Khanassov V, Linda L (2022). Latest Canadian consensus conference on the diagnosis and treatment of dementia for primary care clinicians. Ann Fam Med, 20(20 Suppl 1). Abstract. Author URL.
Ruthirakuhan M, Herrmann N, Ismail Z, Gallagher D, Lanctôt KL (2022). MBI symptoms predict progression to Alzheimer’s disease independent of neuropathology. Alzheimer's & Dementia, 17
Matuskova V, Ismail Z, Nikolai T, Markova H, Cechova K, Nedelska Z, Laczo J, Wang M, Hort J, Vyhnalek M, et al (2022). Mild Behavioral Impairment is Associated with Atrophy of Entorhinal Cortex and Hippocampus in a Memory Clinic Cohort (vol 13, 643271, 2021). FRONTIERS IN AGING NEUROSCIENCE, 14 Author URL.
Nathan S, Ghahremani M, McGirr A, Smith EE, Ismail Z (2022). Mild behavioral impairment and functional connectivity in dementia‐free elderly. Alzheimer's & Dementia, 18(S5).
Ismail Z, Ghahremani M, Chen H, Wang M, Zetterberg H, Smith EE (2022). Mild behavioral impairment is associated with plasma p‐tau181 in a dementia‐free population. Alzheimer's & Dementia, 18(S7).
Ruthirakuhan M, Ismail Z, Herrmann N, Gallagher D, Lanctôt KL (2022). Mild behavioral impairment is associated with progression to Alzheimer's disease: a clinicopathological study. Alzheimer's & Dementia, 18(11), 2199-2208. Abstract.
Lussier FZ, Therriault J, Tissot C, Servaes S, Benedet AL, Ashton NJ, Karikari TK, Chamoun M, Stevenson J, Rahmouni N, et al (2022). Mild behavioral impairment symptom severity predicts tau hyperphosphorylation assessed by plasma p‐tau181 across the Alzheimer’s disease spectrum. Alzheimer's & Dementia, 18(S7).
Saari T, Smith EE, Ismail Z (2022). Network analysis of impulse dyscontrol in mild cognitive impairment and subjective cognitive decline. Int Psychogeriatr, 34(6), 553-562. Abstract. Author URL.
Atchison K, Watt JA, Ewert D, Toohey AM, Ismail Z, Goodarzi Z (2022). Non-pharmacologic and pharmacologic treatments for anxiety in long-term care: a systematic review and meta-analysis. AGE AND AGEING, 51(9). Author URL.
Chen A, Ismail Z, Mann F, Bromet E, Clouston S, Luft B (2022). P91. Behavioral Impairment and Increased Risk of Parietal-Dominant Alzheimer’s Disease Among World Trade Center Responders. Biological Psychiatry, 91(9).
Correll CU, Ismail Z, McIntyre RS, Rafeyan R, Thase ME (2022). Patient Functioning and Life Engagement: Unmet Needs in Major Depressive Disorder and Schizophrenia. J Clin Psychiatry, 83(4). Abstract. Author URL.
Correll CU, Ismail Z, McIntyre RS, Rafeyan R, Thase ME (2022). Patient Functioning, Life Engagement, and Treatment Goals in Major Depressive Disorder. Journal of Clinical Psychiatry, 83(5). Abstract.
Correll CU, Ismail Z, McIntyre RS, Rafeyan R, Thase ME (2022). Patient Functioning, Life Engagement, and Treatment Goals in Schizophrenia. J Clin Psychiatry, 83(5). Abstract. Author URL.
McIntyre RS, Ismail Z, Watling CP, Weiss C, Meehan SR, Musingarimi P, Thase ME (2022). Patient-reported outcome measures for life engagement in mental health: a systematic review. J Patient Rep Outcomes, 6(1). Abstract. Author URL.
Miao R, Chen H-Y, Gill S, Naude J, Smith EE, Ismail Z, Alzheimer’s Disease Neuroimaging Initiative (2022). Plasma β-Amyloid in Mild Behavioural Impairment - Neuropsychiatric Symptoms on the Alzheimer's Continuum. J Geriatr Psychiatry Neurol, 35(3), 434-441. Abstract. Author URL.
Kan CN, Cano J, Zhao X, Ismail Z, Chen CL-H, Xu X (2022). Prevalence, Clinical Correlates, Cognitive Trajectories, and Dementia Risk Associated with Mild Behavioral Impairment in Asians. The Journal of Clinical Psychiatry, 83(3).
McGirr A, Nathan S, Ghahremani M, Gill S, Smith EE, Ismail Z (2022). Progression to Dementia or Reversion to Normal Cognition in Mild Cognitive Impairment as a Function of Late-Onset Neuropsychiatric Symptoms. Neurology, 98(21).
Agüera-Ortiz L, Babulal GM, Bruneau M-A, Creese B, D’Antonio F, Fischer CE, Gatchel JR, Ismail Z, Kumar S, McGeown WJ, et al (2022). Psychosis as a Treatment Target in Dementia: a Roadmap for Designing Interventions. Journal of Alzheimer's Disease, 88(4), 1203-1228. Abstract.
Ismail Z, Creese B, Aarsland D, Kales HC, Lyketsos CG, Sweet RA, Ballard C (2022). Psychosis in Alzheimer disease - mechanisms, genetics and therapeutic opportunities. Nature reviews. Neurology, 18(3), 131-144. Abstract.
Guan DX, Rockwood K, Smith EE, Ismail Z (2022). Sex Moderates the Association between Frailty and Mild Behavioral Impairment. JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE, 9(4), 692-700. Author URL.
Dissanayake AS, Tan YB, Bowie CR, Butters MA, Flint AJ, Gallagher D, Golas AC, Herrmann N, Ismail Z, Kennedy JL, et al (2022). Sex Modifies the Associations of APOEɛ4 with Neuropsychiatric Symptom Burden in Both At-Risk and Clinical Cohorts of Alzheimer's Disease. Journal of Alzheimer's Disease, 90(4), 1571-1588.
Eikelboom WS, Pan M, Ossenkoppele R, Coesmans M, Gatchel JR, Ismail Z, Lanctôt KL, Fischer CE, Mortby ME, van den Berg E, et al (2022). Sex differences in neuropsychiatric symptoms in Alzheimer’s disease dementia: a meta-analysis. Alzheimer's Research and Therapy, 14(1). Abstract.
Roach P, Zwiers A, Cox E, Fischer K, Charlton A, Josephson CB, Patten SB, Seitz D, Ismail Z, Smith EE, et al (2022). Supporting people living with dementia and care partners throughout the COVID‐19 pandemic: Health service directions from the first wave in Calgary, Alberta. Alzheimer's & Dementia, 17(Suppl 7).
Zarei S, Colman S, Rostas A, Burhan AM, Chu L, Davies SJ, Derkach P, Elmi S, Hussain M, Gerretsen P, et al (2022). The Rationale and Design of Behavioral Interventions for Management of Agitation in Dementia in a Multi-Site Clinical Trial. J Alzheimers Dis, 86(2), 827-840. Abstract. Author URL.
Gosselin P, Guan DX, Chen H-Y, Pichora-Fuller MK, Phillips N, Faris P, Smith EE, Ismail Z (2022). The Relationship Between Hearing and Mild Behavioral Impairment and the Influence of Sex: a Study of Older Adults Without Dementia from the COMPASS-ND Study. Journal of Alzheimer's Disease Reports, 6(1), 57-66.
Creese B, Aarsland D, Ballard CG, Brooker H, Corbett A, Ismail Z (2022). The association of the of late‐life onset psychotic symptoms with incident cognitive impairment in a cognitively normal sample. Alzheimer's & Dementia, 18(S7).
Nosheny RL, Amariglio R, Sikkes SAM, Van Hulle C, Bicalho MAC, Dowling NM, Brucki SMD, Ismail Z, Kasuga K, Kuhn E, et al (2022). The role of dyadic cognitive report and subjective cognitive decline in early ADRD clinical research and trials: Current knowledge, gaps, and recommendations. Alzheimers Dement (N Y), 8(1). Abstract. Author URL.
Bray M, Bryant B, Esagoff A, Richey L, Rodriguez C, Krieg A, Cullum CM, Lobue C, Ismail Z, Peters M, et al (2022). Traumatic brain injury alters presentation of mild behavioral impairment domains across progression of all-cause dementia. European Psychiatry, 65(Suppl 1), s172-s173.
Wu Y, Levis B, Sun Y, He C, Krishnan A, Neupane D, Bhandari PM, Negeri Z, Benedetti A, Thombs BD, et al (2021). Accuracy of the Hospital Anxiety and Depression Scale Depression subscale (HADS-D) to screen for major depression: systematic review and individual participant data meta-analysis. BMJ, 373 Abstract. Author URL.
De Mauleon A, Ismail Z, Rosenberg P, Miller D, Cantet C, O'Gorman C, Vellas B, Lyketsos C, Soto M (2021). Agitation in Alzheimer's disease: Novel outcome measures reflecting the International Psychogeriatric Association (IPA) agitation criteria. Alzheimers Dement, 17(10), 1687-1697. Abstract. Author URL.
Mortby ME, Adler L, Agüera‐Ortiz L, Bateman DR, Brodaty H, Cantillon M, Geda YE, Ismail Z, Lanctôt KL, Marshall GA, et al (2021). Apathy as a treatment target in neurocognitive disorders: Clinical trial implications. Alzheimer's & Dementia, 17(S6).
Ng KP, Chiew H, Rosa-Neto P, Kandiah N, Ismail Z, Gauthier S (2021). Associations of AT(N) biomarkers with neuropsychiatric symptoms in preclinical Alzheimer's disease and cognitively unimpaired individuals. Transl Neurodegener, 10(1). Abstract. Author URL.
Hu S, Patten SB, Charlton A, Fischer K, Fick G, Smith EE, Ismail Z (2021). Associations of neuropsychiatric symptoms with cognitive impairment: the utility of the mild behavioral impairment checklist and the neuropsychiatric interview questionnaire in a cognitive neurology clinic population. Alzheimer's & Dementia, 17(S6).
Smith EE, Crites S, Wang M, Charlton A, Zwiers A, Sekhon R, Sajobi T, Camicioli R, McCreary CR, Frayne R, et al (2021). Cerebral Amyloid Angiopathy is Associated with Emotional Dysregulation, Impulse Dyscontrol, and Apathy. J Am Heart Assoc, 10(22). Abstract. Author URL.
MacLean D, Zwiers A, Cox E, Ismail Z, Camicioli R, Smith EE (2021). Cerebral amyloid angiopathy and visuospatial functioning: Analysis of the clock drawing test. Alzheimer's & Dementia, 17(S6).
Kassam F, Chen H, Nosheny RL, McGirr A, Williams T, Ng N, Camacho M, Mackin RS, Weiner MW, Ismail Z, et al (2021). Cognitive profile of mild behavioral impairment in Brain Health Registry participants. Abstract.
Callahan BL, Plamondon A, Gill S, Ismail Z (2021). Contribution of vascular risk factors to the relationship between ADHD symptoms and cognition in adults and seniors. Sci Rep, 11(1). Abstract. Author URL.
Subotic A, McCreary CR, Saad F, Nguyen A, Alvarez-Veronesi A, Zwiers AM, Charlton A, Beaudin AE, Ismail Z, Pike GB, et al (2021). Cortical Thickness and its Association with Clinical Cognitive and Neuroimaging Markers in Cerebral Amyloid Angiopathy. J Alzheimers Dis, 81(4), 1663-1671. Abstract. Author URL.
Cole J, Selby B, Ismail Z, McGirr A (2021). D-cycloserine normalizes long-term motor plasticity after transcranial magnetic intermittent theta-burst stimulation in major depressive disorder. Clinical Neurophysiology, 132(8), 1770-1776. Abstract.
Zarei S, Choudhury S, Burhan AM, Chu L, Colman S, Derkach P, Elmi S, Hussain M, Ismail Z, Zarei S, et al (2021). Determinants of polypharmacy in patients with behavioral and psychological symptoms of dementia. Alzheimer's & Dementia, 17(S6).
Cummings JL, Ismail Z, Dickerson BC, Ballard C, Grossberg G, McEvoy B, Foff E, Atri A (2021). Development and assessment of a brief screening tool for psychosis in dementia. Alzheimer's & Dementia Diagnosis Assessment & Disease Monitoring, 13(1).
Cummings JL, Atri A, Ismail Z, Dickerson BC, Ballard C, Grossberg GT, McEvoy B, Foff E (2021). Development and assessment of a brief screening tool for psychosis in dementia. Alzheimers Dement, 17 Suppl 8 Abstract. Author URL.
Miller DS, Robert P, Ereshefsky L, Adler L, Bateman D, Cummings J, DeKosky ST, Fischer CE, Husain M, Ismail Z, et al (2021). Diagnostic criteria for apathy in neurocognitive disorders. Alzheimers Dement, 17(12), 1892-1904. Abstract. Author URL.
Guan DX, Chen H, Camicioli R, Montero‐Odasso M, Smith EE, Ismail Z (2021). Dual‐task gait and mild behavioral impairment: Findings on the interface between non‐cognitive dementia markers in the COMPASS‐ND study. Alzheimer's & Dementia, 17(S6).
Weiss C, Meehan SR, Brown TM, Gupta C, Mørup MF, Thase ME, McIntyre RS, Ismail Z (2021). Effects of adjunctive brexpiprazole on calmness and life engagement in major depressive disorder: post hoc analysis of patient-reported outcomes from clinical trial exit interviews. Journal of Patient-Reported Outcomes, 5(1). Abstract.
Sun N, Ismail Z, Aarsland D, Brooker H, Corbett A, Ballard C, Creese B (2021). Examination of cognitive performance and mild behavioral impairment domains of apathy, mood, impulse dyscontrol, social inappropriateness and psychosis in cognitively normal adults aged 50 and over. Alzheimer's & Dementia, 17(S6).
Shysh AC, Ismail Z, Sidhu D, Guo M, Nguyen LT, Naugler C (2021). Factors Associated with Hyponatremia in Patients Newly Prescribed Citalopram: a Retrospective Observational Study. Drugs Real World Outcomes, 8(4), 555-563. Abstract. Author URL.
Rouse HJ, Small BJ, Ismail Z (2021). Impact of mild behavioral impairment on longitudinal changes in cognitive performance. Alzheimer's & Dementia, 17(S6).
Wang M, Smith EE, Forkert ND, Chekouo T, Ismail Z, Ganesh A, Sajobi T (2021). Integrating expert knowledge for dementia risk prediction in individuals with mild cognitive impairment (MCI): a study protocol. BMJ Open, 11(11).
Mallo SC, Lojo‐Seoane C, Campos‐Magdaleno M, Vieites AN, Facal D, Ismail Z, Juncos‐Rabadán O, Pereiro AX (2021). Longitudinal differences in instrumental activities of daily living (AIDLs) in participants with subjective cognitive complaints (SCCs) according to neuropsychiatric symptoms (NPS) severity. Alzheimer's & Dementia, 17(S6).
Chen H, Robert P, Nathan S, Smith EE, Ismail Z (2021). MRI and CSF markers of mild behavioural impairment: Findings from the MEMENTO cohort study. Alzheimer's & Dementia, 17(S6).
Matuskova V, Ismail Z, Nikolai T, Markova H, Cechova K, Nedelska Z, Laczó J, Wang M, Hort J, Vyhnalek M, et al (2021). Mild Behavioral Impairment is Associated with Atrophy of Entorhinal Cortex and Hippocampus in a Memory Clinic Cohort. Front Aging Neurosci, 13 Abstract. Author URL.
Ismail Z, McGirr A, Gill S, Hu S, Forkert ND, Smith EE (2021). Mild Behavioral Impairment and Subjective Cognitive Decline Predict Cognitive and Functional Decline. J Alzheimers Dis, 80(1), 459-469. Abstract. Author URL.
Johansson M, Stomrud E, Insel PS, Leuzy A, Johansson PM, Smith R, Ismail Z, Janelidze S, Palmqvist S, van Westen D, et al (2021). Mild behavioral impairment and its relation to tau pathology in preclinical Alzheimer’s disease. Translational Psychiatry, 11(1). Abstract.
Ismail Z, Chen H, Gill S, Naude J, Smith EE (2021). Mild behavioral impairment is associated with amyloid, tau and neurodegeneration in mild cognitive impairment. Alzheimer's & Dementia, 17(S6).
Kan CN, Cano J, Chan V, Ismail Z, Zhao X, Chen C, Xu X (2021). Mild behavioral impairment: Prevalence, clinical profile, and prognosis in a memory clinic cohort in Singapore. Alzheimer's & Dementia, 17(S6).
Tuladhar A, Moore JA, Ismail Z, Forkert ND (2021). Modeling Neurodegeneration in silico with Deep Learning. Frontiers in Neuroinformatics, 15
Smith EE, Ismail Z (2021). Mortality Risk Models for Persons with Dementia: a Systematic Review. J Alzheimers Dis, 80(1), 103-111. Abstract. Author URL.
Matsuoka T, Ueno D, Ismail Z, Rubinstein E, Uchida H, Mimura M, Narumoto J (2021). Neural Correlates of Mild Behavioral Impairment: a Functional Brain Connectivity Study Using Resting-State Functional Magnetic Resonance Imaging. J Alzheimers Dis, 83(3), 1221-1231. Abstract. Author URL.
Gill S, Wang M, Mouches P, Rajashekar D, Sajobi T, MacMaster FP, Smith EE, Forkert ND, Ismail Z, Alzheimer's Disease Neuroimaging Initiative, et al (2021). Neural correlates of the impulse dyscontrol domain of mild behavioral impairment. Int J Geriatr Psychiatry, 36(9), 1398-1406. Abstract. Author URL.
Mele B, Ismail Z, Goodarzi Z, Pringsheim T, Lew G, Holroyd-Leduc J (2021). Non-pharmacologic interventions to treat apathy in Parkinson's disease: a realist review. Clin Park Relat Disord, 4 Abstract. Author URL.
Guan LT, Sekhon R, Kaur S, Chen H, K.V. VW, Burhan AM, Colman S, Derkach P, Elmi S, Hussain M, et al (2021). Novel measures to assess the association of IPA agitation criteria domains with cognition, caregiver burden and quality of life in dementia. Alzheimer's & Dementia, 17(S6).
Jin Yoon E, Ismail Z, Kathol I, Kibreab M, Hammer T, Lang S, Ramezani M, Auclair-Ouellet N, Sarna JR, Martino D, et al (2021). Patterns of brain activity during a set-shifting task linked to mild behavioral impairment in Parkinson’s disease. NeuroImage: Clinical, 30, 102590-102590.
Miao R, Chen H-Y, Gill S, Naude J, Smith EE, Ismail Z (2021). Plasma β-amyloid in mild behavioural impairment – neuropsychiatric symptoms on the Alzheimer’s continuum. Abstract.
Pan Y, Shea YF, Ismail Z, Li VO, Lam JC (2021). Prevalence of mild behavioral impairment subdomains: a meta‐analysis. Alzheimer's & Dementia, 17(S6).
Pan Y, Shea Y, Ismail Z, Mak HK, Chiu PK, Chu L, Song Y (2021). Prevalence of mild behavioural impairment domains: a meta‐analysis. Psychogeriatrics, 22(1), 84-98. Abstract.
Wu Y, Levis B, Ioannidis JPA, Benedetti A, Thombs BD, DEPRESsion Screening Data (DEPRESSD) Collaboration (2021). Probability of Major Depression Classification Based on the SCID, CIDI, and MINI Diagnostic Interviews: a Synthesis of Three Individual Participant Data Meta-Analyses. Psychother Psychosom, 90(1), 28-40. Abstract. Author URL.
Xu L, Li T, Xiong L, Wang X, Ismail Z, Fukuda M, Sun Z, Wang J, Gauthier S, Yu X, et al (2021). Reliability and Validity of the Chinese Version of Mild Behavioral Impairment Checklist in Mild Cognitive Impairment and Mild Alzheimer's Disease. J Alzheimers Dis, 81(3), 1141-1149. Abstract. Author URL.
McGirr A, Devoe DJ, Raedler A, Debert CT, Ismail Z, Berlim MT (2021). Repetitive Transcranial Magnetic Stimulation for the Treatment of Post-traumatic Stress Disorder: a Systematic Review and Network Meta-analysis: La Stimulation Magnétique Transcrânienne Répétitive Pour le Traitement du Trouble de Stress Post-Traumatique : Une Revue Systématique et une Méta-Analyse en Réseau. Canadian Journal of Psychiatry, 66(9), 763-773. Abstract.
Creese B, Arathimos R, Brooker H, Corbett A, Aarsland D, Lewis C, Ballard C, Ismail Z (2021). Self and informant‐rated mild behavioral impairment and genetic risk for AD: the respondent matters. Alzheimer's & Dementia, 17(S6).
Rehman T, McGirr A, Ismail Z (2021). Self‐reported and informant‐reported depressive symptoms are independent and divergent predictors of new onset dementia in older adults. Alzheimer's & Dementia, 17(S6).
Eikelboom WS, Pan M, Ossenkoppele R, Coesmans M, Gatchel JR, Ismail Z, Lanctôt KL, Fischer CE, Mortby ME, van den Berg E, et al (2021). Sex differences in neuropsychiatric symptoms in Alzheimer’s disease dementia: a meta‐analysis. Alzheimer's & Dementia, 17(S6).
Wolfova K, Creese B, Aarsland D, Ismail Z, Corbett A, Ballard C, Hampshire A, Cermakova P (2021). Sex differences in the association of mild behavioral impairment with cognitive aging. Abstract.
Soo SA, Ng KP, Wong F, Saffari SE, Yatawara C, Ismail Z, Kandiah N (2021). The Association Between Diabetes Mellitus and Mild Behavioral Impairment Among Mild Cognitive Impairment: Findings from Singapore. J Alzheimers Dis, 82(1), 411-420. Abstract. Author URL.
Guan DX, Gosselin P, Chen H, Pichora‐Fuller MK, Phillips N, Smith EE, Ismail Z (2021). The relationship between subjective hearing impairment and mild behavioral impairment – a study of older adults without dementia in the COMPASS‐ND Study. Alzheimer's & Dementia, 17(S6).
Miao R, Chen H-Y, Robert P, Smith EE, Ismail Z, Group TMS (2021). White matter hyperintensities and mild behavioral impairment: Findings from the MEMENTO cohort study. Cerebral Circulation - Cognition and Behavior, 2
Miao R, Chen H, Robert P, Smith EE, Ismail Z (2021). White matter hyperintensities and mild behavioural impairment: Findings from the MEMENTO Study. Alzheimer's & Dementia, 17(S6).
Nogovitsyn N, Souza R, Muller M, Srajer A, Metzak PD, Hassel S, Ismail Z, Protzner A, Bray SL, Lebel C, et al (2020). Aberrant limbic brain structures in young individuals at risk for mental illness. Psychiatry Clin Neurosci, 74(5), 294-302. Abstract. Author URL.
Bateman DR, Gill S, Hu S, Foster ED, Ruthirakuhan MT, Sellek AF, Mortby ME, Matušková V, Ng KP, Tarawneh RM, et al (2020). Agitation and impulsivity in mid and late life as possible risk markers for incident dementia. Alzheimers Dement (N Y), 6(1). Abstract. Author URL.
Montero-Odasso M, Ismail Z, Camicioli R (2020). Alzheimer Disease, Biomarkers, and Clinical Symptoms-Quo Vadis?. JAMA Neurol, 77(3), 393-394. Author URL.
Nathan S, Gill S, Ismail Z (2020). ApoE ε4 status in pre‐dementia risk states, mild behavioural impairment and subjective cognitive decline, and the risk of incident cognitive decline. Alzheimer's & Dementia, 16(S6).
Ramezani M, Ruskey JA, Martens K, Kibreab M, Javer Z, Kathol I, Hammer T, Cheetham J, Leveille E, Martino D, et al (2020). Association Between BDNF Val66Met Polymorphism and Mild Behavioral Impairment in Patients with Parkinson's Disease. Front Neurol, 11 Abstract. Author URL.
Tuladhar A, Gill S, Ismail Z, Forkert ND, Alzheimer's Disease Neuroimaging Initiative (2020). Building machine learning models without sharing patient data: a simulation-based analysis of distributed learning by ensembling. J Biomed Inform, 106 Abstract. Author URL.
Tang-Wai DF, Smith EE, Bruneau MA, Burhan AM, Chatterjee A, Chertkow H, Choudhury S, Dorri E, Ducharme S, Fischer CE, et al (2020). CCCDTD5 recommendations on early and timely assessment of neurocognitive disorders using cognitive, behavioral, and functional scales. Alzheimer's and Dementia: Translational Research and Clinical Interventions, 6(1). Abstract.
Montero-Odasso M, Pieruccini-Faria F, Ismail Z, Li K, Lim A, Phillips N, Kamkar N, Sarquis-Adamson Y, Speechley M, Theou O, et al (2020). CCCDTD5 recommendations on early non cognitive markers of dementia: a Canadian consensus. Alzheimers Dement (N Y), 6(1). Abstract. Author URL.
Brisson M, Brodeur C, Létourneau-Guillon L, Masellis M, Stoessl J, Tamm A, Zukotynski K, Ismail Z, Gauthier S, Rosa-Neto P, et al (2020). CCCDTD5: Clinical role of neuroimaging and liquid biomarkers in patients with cognitive impairment. Alzheimers Dement (N Y), 6(1). Abstract. Author URL.
Gauthier S, Chertkow H, Theriault J, Chayer C, Ménard M-C, Lacombe G, Rosa-Neto P, Ismail Z (2020). CCCDTD5: research diagnostic criteria for Alzheimer's Disease. Alzheimers Dement (N Y), 6(1). Abstract. Author URL.
Wong F, Ng KP, Yatawara C, Low A, Ismail Z, Kandiah N (2020). Characterising mild behavioural impairment in Asian mild cognitive impairment and cognitively normal individuals. Alzheimer's & Dementia, 16(S6).
Kassam F, Chen H, Nosheny RL, Williams T, Mackin RS, Weiner MW, Ismail Z (2020). Cognitive profile of mild behavioral impairment (MBI) in brain health registry participants. Alzheimer's & Dementia, 16(S6).
Lang S, Ismail Z, Kibreab M, Kathol I, Sarna J, Monchi O (2020). Common and unique connectivity at the interface of motor, neuropsychiatric, and cognitive symptoms in Parkinson's disease: a commonality analysis. HUMAN BRAIN MAPPING, 41(13), 3749-3764. Author URL.
Cummings J, Pinto LC, Cruz M, Fischer CE, Gerritsen DL, Grossberg GT, Hwang TJ, Ismail Z, Jeste DV, Koopmans R, et al (2020). Criteria for Psychosis in Major and Mild Neurocognitive Disorders: International Psychogeriatric Association (IPA) Consensus Clinical and Research Definition. American Journal of Geriatric Psychiatry, 28(12), 1256-1269. Abstract.
Brehaut E, Neupane D, Levis B, Wu Y, Sun Y, Krishnan A, He C, Bhandari PM, Negeri Z, Riehm KE, et al (2020). Depression prevalence using the HADS-D compared to SCID major depression classification: an individual participant data meta-analysis. Journal of Psychosomatic Research, 139 Abstract.
Mele B, Van S, Holroyd-Leduc J, Ismail Z, Pringsheim T, Goodarzi Z (2020). Diagnosis, treatment and management of apathy in Parkinson's disease: a scoping review. BMJ Open, 10(9). Abstract. Author URL.
Mallo SC, Patten SB, Ismail Z, Pereiro AX, Facal D, Otero C, Juncos-Rabadán O (2020). Does the neuropsychiatric inventory predict progression from mild cognitive impairment to dementia? a systematic review and meta-analysis. Ageing Res Rev, 58 Abstract. Author URL.
Meade N, Shi L, Meehan SR, Weiss C, Ismail Z (2020). Efficacy and safety of brexpiprazole in patients with schizophrenia presenting with severe symptoms: Post-hoc analysis of short- and long-term studies. J Psychopharmacol, 34(8), 829-838. Abstract. Author URL.
Huang V, Hogan DB, Ismail Z, Maxwell CJ, Smith EE, Callahan BL (2020). Evaluating the Real-World Representativeness of Participants with Mild Cognitive Impairment in Canadian Research Protocols: a Comparison of the Characteristics of a Memory Clinic Patients and Research Samples. Can Geriatr J, 23(4), 297-328. Abstract. Author URL.
Sharma B, Gee M, Zwiers A, Sekhon R, Charlton A, Ismail Z, Camicioli R, Smith EE (2020). Gait impairments on single and dual tasks in cerebral amyloid angiopathy. Alzheimer's & Dementia, 16(S6).
Creese B, Brooker H, Aarsland D, Corbett A, Ballard C, Ismail Z (2020). Genetic risk for Alzheimer disease, cognition and Mild Behavioral Impairment in healthy older adults. Abstract.
Nogovitsyn N, Muller M, Souza R, Hassel S, Arnott SR, Davis AD, Hall GB, Harris JK, Zamyadi M, Metzak PD, et al (2020). Hippocampal tail volume as a predictive biomarker of antidepressant treatment outcomes in patients with major depressive disorder: a CAN-BIND report. Neuropsychopharmacology, 45(2), 283-291. Abstract. Author URL.
Ismail Z, Pedersen AM, Thase ME, Rasmussen Meehan S, Weiss C, Groes Larsen K, Chen D, Nylander A-G, Baker RA, McIntyre R, et al (2020). M191. EFFECT OF BREXPIPRAZOLE ON ENGAGEMENT IN PATIENTS WITH SCHIZOPHRENIA: POST-HOC ANALYSIS OF THREE STUDIES. Schizophrenia bulletin, 46(Suppl 1), S208-S209. Abstract.
Ismail Z, McGirr A, Gill S, Hu S, Forkert ND, Smith EE (2020). Mild Behavioral Impairment and Subjective Cognitive Decline predict Mild Cognitive Impairment. Abstract.
Soo SA, Ng KP, Wong F, Yatawara C, Chiew HJ, Ng ASL, Ismail Z, Kandiah N (2020). Mild Behaviour Impairment Checklist (MBI‐C): is there a difference in ratings between patient and close informant?. Alzheimer's & Dementia, 16(S6).
Ismail Z, Gill S, Wang M, Naude J, Smith EE (2020). Mild behavioral impairment associates with Alzheimer’s disease biomarkers and greater risk of incident dementia in patients with MCI. Alzheimer's & Dementia, 16(S6).
Lang S, Yoon EJ, Kibreab M, Kathol I, Cheetham J, Hammer T, Sarna J, Ismail Z, Monchi O (2020). Mild behavioral impairment in Parkinson's disease is associated with altered corticostriatal connectivity. Neuroimage Clin, 26 Abstract. Author URL.
Matuskova V, Ismail Z, Nikolai T, Markova H, Cechova K, Laczó J, Nedelska Z, Lerch O, Hort J, Vyhnalek M, et al (2020). Mild behavioral impairment is associated with atrophy in Alzheimer's disease‐related regions in non‐demented older adults. Alzheimer's & Dementia, 16(S6).
Lussier FZ, Pascoal TA, Chamoun M, Therriault J, Tissot C, Savard M, Kang MS, Mathotaarachchi S, Benedet AL, Parsons M, et al (2020). Mild behavioral impairment is associated with β-amyloid but not tau or neurodegeneration in cognitively intact elderly individuals. Alzheimers Dement, 16(1), 192-199. Abstract. Author URL.
Fan S, Liang X, Yun T, Pei Z, Hu B, Ismail Z, Yang Z, Xu F (2020). Mild behavioral impairment is related to frailty in non-dementia older adults: a cross-sectional study. BMC Geriatrics, 20(1). Abstract.
Fan S, Liang X, Yun T, Pei Z, Hu B, Ismail Z, Yang Z, Xu F (2020). Mild behavioral impairment is related to frailty in non-dementia older adults: a cross-sectional study. Abstract.
Saari T, Smith EE, Ismail Z (2020). Network analysis of impulse dyscontrol in mild cognitive impairment and subjective cognitive decline. Abstract.
Gill S, Wang M, Mouches P, Rajashekar D, Sajobi T, MacMaster FP, Smith EE, Forkert ND, Ismail Z (2020). Neural Correlates of the Impulse Dyscontrol Domain of Mild Behavioral Impairment. Abstract.
Mallo SC, Pereiro AX, Campos‐Magdaleno M, Nieto‐Vieites A, Lojo‐Seoane C, Facal D, Ismail Z, Juncos‐Rabadán O (2020). Neuropsychiatric symptoms in subjective cognitive complaints (SCC) and mild cognitive impairment (MCI): Detecting changes over time with the Mild Behavioral Impairment Checklist (MBI‐C). Alzheimer's & Dementia, 16(S6).
Montero-Odasso M, Ismail Z, Livingston G (2020). One third of dementia cases can be prevented within the next 25 years by tackling risk factors. The case "for" and "against". Alzheimers Res Ther, 12(1). Abstract. Author URL.
Smith EE, Couillard P, Fisk JD, Ismail Z, Montero-Odasso M, Robillard JM, Vedel I, Sivananthan S, Gauthier S (2020). Pandemic Dementia Scarce Resource Allocation. Can Geriatr J, 23(3), 216-218. Abstract. Author URL.
Fiest KM, Krewulak KD, Ely EW, Davidson JE, Ismail Z, Sept BG, Stelfox HT (2020). Partnering with Family Members to Detect Delirium in Critically Ill Patients. Crit Care Med, 48(7), 954-961. Abstract. Author URL.
Naude JP, Gill S, Hu S, McGirr A, Forkert ND, Monchi O, Stys PK, Smith EE, Ismail Z, Alzheimer’s Disease Neuroimaging Initiative, et al (2020). Plasma Neurofilament Light: a Marker of Neurodegeneration in Mild Behavioral Impairment. J Alzheimers Dis, 76(3), 1017-1027. Abstract. Author URL.
(2020). Poster Presentations at the 10th Canadian Conference on Dementia (CCD), Québec City, October 3, 2019. Can Geriatr J, 23(1), 4-87. Author URL.
Wu Y, Levis B, Sun Y, Krishnan A, He C, Riehm KE, Rice DB, Azar M, Yan XW, Neupane D, et al (2020). Probability of major depression diagnostic classification based on the SCID, CIDI and MINI diagnostic interviews controlling for Hospital Anxiety and Depression Scale - Depression subscale scores: an individual participant data meta-analysis of 73 primary studies. J Psychosom Res, 129 Abstract. Author URL.
Ismail Z, Black SE, Camicioli R, Chertkow H, Herrmann N, Laforce R, Montero-Odasso M, Rockwood K, Rosa-Neto P, Seitz D, et al (2020). Recommendations of the 5th Canadian Consensus Conference on the diagnosis and treatment of dementia. Alzheimer's and Dementia, 16(8), 1182-1195. Abstract.
Creese B, Brooker H, Aarsland D, Corbett A, Ballard C, Ismail Z (2020). Relationship between genetic risk for Alzheimer's, cognition and neuropsychiatric symptoms: a case study of DNA sampling and analysis through digital platform cohort studies. Alzheimer's & Dementia, 16(S10).
Geddes MR, O'Connell ME, Fisk JD, Gauthier S, Camicioli R, Ismail Z, Alzheimer Society of Canada Task Force on Dementia Care Best Practices for COVID‐19 (2020). Remote cognitive and behavioral assessment: Report of the Alzheimer Society of Canada Task Force on dementia care best practices for COVID-19. Alzheimers Dement (Amst), 12(1). Abstract. Author URL.
Joyce JM, Monchi O, Ismail Z, Kibreab M, Cheetham J, Kathol I, Sarna J, Martino D, Debert CT (2020). The impact of traumatic brain injury on cognitive and neuropsychiatric symptoms of Parkinson's disease. Int Rev Psychiatry, 32(1), 46-60. Abstract. Author URL.
McDade E, Bednar MM, Brashear HR, Miller DS, Maruff P, Randolph C, Ismail Z, Carrillo MC, Weber CJ, Bain LJ, et al (2020). The pathway to secondary prevention of Alzheimer's disease. Alzheimers Dement (N Y), 6(1). Abstract. Author URL.
Ganesh A, Barber P, Black SE, Corbett D, Field TS, Frayne R, Hachinski V, Ismail Z, Mai LM, McCreary CR, et al (2020). Trial of remote ischaemic preconditioning in vascular cognitive impairment (TRIC-VCI): protocol. BMJ Open, 10(10), e040466-e040466. Abstract.
Roach P, Zwiers A, Cox E, Fischer K, Charlton A, Josephson CB, Patten SB, Seitz D, Ismail Z, Smith EE, et al (2020). Understanding the impact of the COVID-19 pandemic on well-being and virtual care for people living with dementia and care partners living in the community. Dementia, 20(6), 2007-2023. Abstract.
Roach P, Zwiers A, Cox E, Fischer K, Charlton A, Josephson CB, Patten SB, Seitz D, Ismail Z, Smith EE, et al (2020). Understanding the impact of the COVID-19 pandemic on well-being and virtual care for people living with dementia and care partners living in the community. Abstract.
Gill S, Mouches P, Hu S, Rajashekar D, MacMaster FP, Smith EE, Forkert ND, Ismail Z, Alzheimer’s Disease Neuroimaging Initiative (2020). Using Machine Learning to Predict Dementia from Neuropsychiatric Symptom and Neuroimaging Data. J Alzheimers Dis, 75(1), 277-288. Abstract. Author URL.
Ismail Z, Gatchel J, Bateman DR, Barcelos-Ferreira R, Cantillon M, Jaeger J, Donovan NJ, Mortby ME (2019). Affective and emotional dysregulation as pre-dementia risk markers: exploring the mild behavioral impairment symptoms of depression, anxiety, irritability, and euphoria - CORRIGENDUM. Int Psychogeriatr, 31(1). Author URL.
Mallo SC, Ismail Z, Pereiro AX, Facal D, Lojo-Seoane C, Campos-Magdaleno M, Juncos-Rabadán O (2019). Assessing mild behavioral impairment with the mild behavioral impairment checklist in people with subjective cognitive decline. Int Psychogeriatr, 31(2), 231-239. Abstract. Author URL.
Ng KP, Chiew HJ, Rosa-Neto P, Kandiah N, Ismail Z, Gauthier S (2019). Brain Metabolic Dysfunction in Early Neuropsychiatric Symptoms of Dementia. Front Pharmacol, 10 Abstract. Author URL.
Showraki A, Murari G, Ismail Z, Barfett JJ, Fornazzari L, Munoz DG, Schweizer TA, Fischer CE (2019). Cerebrospinal Fluid Correlates of Neuropsychiatric Symptoms in Patients with Alzheimer's Disease/Mild Cognitive Impairment: a Systematic Review. J Alzheimers Dis, 71(2), 477-501. Abstract. Author URL.
Colijn MA, Ismail Z (2019). Clinically Relevant Anti-Neuronal Cell Surface Antibodies in Schizophrenia Spectrum Disorders. Neuropsychobiology, 78(2), 70-78. Abstract. Author URL.
Agϋera-Ortiz L, Lyketsos C, Ismail Z (2019). Comment on "Personality Changes During the Transition from Cognitive Health to Mild Cognitive Impairment". J Am Geriatr Soc, 67(1), 190-191. Author URL.
Mele B, Merrikh D, Ismail Z, Goodarzi Z (2019). Detecting Apathy in Individuals with Parkinson's Disease: a Systematic Review. J Parkinsons Dis, 9(4), 653-664. Abstract. Author URL.
Goodarzi Z, Samii L, Azeem F, Sekhon R, Crites S, Pringsheim T, Smith EE, Ismail Z, Holroyd-Leduc J (2019). Detection of anxiety symptoms in persons with dementia: a systematic review. Alzheimers Dement (Amst), 11, 340-347. Abstract. Author URL.
Gill S, Wang M, Forkert ND, MacMaster FP, Smith EE, Ismail Z (2019). Diffusion Tensor Imaging in pre-dementia risk states: white matter atrophy findings in Mild Behavioral Impairment (P5.1-025). Neurology, 92(15_supplement).
Gosselin PA, Ismail Z, Faris PD, Benkoczi CL, Fraser TL, Cherry SW, Faulkner TI, Islam MS (2019). Effect of Hearing Ability and Mild Behavioural Impairment on MoCA and Memory Index Scores. Can Geriatr J, 22(3), 165-170. Abstract. Author URL.
Ehrhardt S, Porsteinsson AP, Munro CA, Rosenberg PB, Pollock BG, Devanand DP, Mintzer J, Rajji TK, Ismail Z, Schneider LS, et al (2019). Escitalopram for agitation in Alzheimer's disease (S-CitAD): Methods and design of an investigator-initiated, randomized, controlled, multicenter clinical trial. Alzheimers Dement, 15(11), 1427-1436. Abstract. Author URL.
Qian W, Schweizer TA, Churchill NW, Millikin C, Ismail Z, Smith EE, Lix LM, Munoz DG, Barfett JJ, Rajji TK, et al (2019). Gray Matter Changes Associated with the Development of Delusions in Alzheimer Disease. Am J Geriatr Psychiatry, 27(5), 490-498. Abstract. Author URL.
Talai AS, Ismail Z, Sedlacik J, Boelmans K, Forkert ND (2019). Improved Automatic Morphology-Based Classification of Parkinson's Disease and Progressive Supranuclear Palsy. Clin Neuroradiol, 29(4), 605-614. Abstract. Author URL.
Elefante C, Lattanzi L, Ismail Z, Medda P, Bacciardi S, Mainardi C, Perugi G (2019). Mild Behavioral Impairment: presentation of the diagnostic criteria and the Italian version of the MBI-Checklist. Riv Psichiatr, 54(2), 59-66. Abstract. Author URL.
Yoon EJ, Ismail Z, Hanganu A, Kibreab M, Hammer T, Cheetham J, Kathol I, Sarna JR, Martino D, Furtado S, et al (2019). Mild behavioral impairment is linked to worse cognition and brain atrophy in Parkinson disease. Neurology, 93(8), e766-e777. Abstract. Author URL.
Lussier FZ, Pascoal TA, Chamoun M, Therriault J, Tissot C, Savard M, Mathotaarachchi S, Kang MS, Benedet AL, Thomas E, et al (2019). O2‐11‐05: MILD BEHAVIORAL IMPAIRMENT IS ASSOCIATED WITH β‐AMYLOID BUT NOT WITH TAU IN COGNITIVELY INTACT ELDERLY INDIVIDUALS. Alzheimer's & Dementia, 15(7S_Part_11), p569-p570.
Mallo SC, Juncos-Rabadán O, Facal D, Ismail Z, Sikkes SAM, Campos-Magdaleno M, Lojo-Seoane C, Nieto-Vieites A, Pereiro AX (2019). P1‐277: THE ROLE OF THE MILD BEHAVIORAL IMPAIRMENT‐CHECKLIST IN PREDICTING FUNCTIONALITY IN THE CONTINUUM FROM NORMAL AGING TO MILD COGNITIVE IMPAIRMENT. Alzheimer's & Dementia, 15(7S_Part_6), p346-p347.
Hu S, Patten SB, Fick G, Smith EE, Ismail Z (2019). P1‐317: VALIDATION OF THE MILD BEHAVIORAL IMPAIRMENT CHECKLIST (MBI‐C) IN a CLINIC‐BASED SAMPLE. Alzheimer's & Dementia, 15(7S_Part_7), p365-p365.
Creese B, Brooker H, Wesnes K, Corbett A, Aarsland D, Ismail Z, Ballard C (2019). P1‐468: CHARACTERISING THE COGNITIVE PROFILE ASSOCIATED WITH INDIVIDUAL DOMAINS OF MID BEHAVIOURAL IMPAIRMENT IN THE COGNITIVELY NORMAL POPULATION. Alzheimer's & Dementia, 15(7S_Part_8), p447-p448.
Black SA, Templeton GW, Hernandez Y, Fischer K, Barber P, Ismail Z, Smith EE, Zetterberg H, Stys PK, Tsutsui S, et al (2019). P3‐223: AMIRASPEC: BLOOD CELL FLUORESCENCE FOR THE DIAGNOSIS OF ALZHEIMER'S DISEASE. Alzheimer's & Dementia, 15(7S_Part_19), p1016-p1017.
Creese B, Brooker H, Corbett A, Ismail Z, Aarsland D, Ballard C (2019). P4‐248: EVALUATING SHARED GENETIC LIABILITY FOR LATE‐LIFE ABNORMAL THOUGHTS AND PERCEPTION (MILD BEHAVIORAL IMPAIRMENT), AND NEUROLOGICAL AND PSYCHIATRIC CONDITIONS. Alzheimer's & Dementia, 15(7S_Part_26), p1374-p1374.
Gill S, Mouches P, Wang M, MacMaster FP, Smith EE, Forkert ND, Ismail Z (2019). P4‐266: USING MACHINE LEARNING TO IDENTIFY NEUROIMAGING AND CLINICAL FEATURES OF MILD BEHAVIORAL IMPAIRMENT (MBI). Alzheimer's & Dementia, 15(7S_Part_26), p1383-p1383.
Ismail Z, Hu S, Gill S, Forkert ND, Smith EE (2019). P4‐566: SUBJECTIVE COGNITIVE DECLINE (SCD) AND MILD BEHAVIORAL IMPAIRMENT (MBI) TOGETHER PREDICT MILD COGNITIVE IMPAIRMENT AT 3 YEARS BETTER THAN EITHER SYNDROME ALONE. Alzheimer's & Dementia, 15(7S_Part_29), p1535-p1536.
Matsuoka T, Ismail Z, Narumoto J (2019). Prevalence of Mild Behavioral Impairment and Risk of Dementia in a Psychiatric Outpatient Clinic. J Alzheimers Dis, 70(2), 505-513. Abstract. Author URL.
Creese BA, Griffiths A, Brooker H, Corbett A, Aarsland D, Ballard C, Ismail Z (2019). Profile of Mild Behavioral Impairment and Factor Structure of the Mild Behavioral Impairment Checklist in Cognitively Normal Older Adults. International Psychogeriatrics
Creese B, Griffiths A, Brooker H, Corbett A, Aarsland D, Ballard C, Ismail Z (2019). Profile of mild behavioral impairment and factor structure of the Mild Behavioral Impairment Checklist in cognitively normal older adults. International Psychogeriatrics, 32(6), 705-717. Abstract.
Huang V, Hogan DB, Ismail Z, Maxwell CJ, Smith EE, Callahan BL (2019). REAL-WORLD REPRESENTATIVENESS OF CANADIAN RESEARCH SUBJECTS WITH MILD COGNITIVE IMPAIRMENT. Innovation in aging, 3(Suppl 1), S660-S661. Abstract.
Kennedy SH, Lam RW, Rotzinger S, Milev RV, Blier P, Downar J, Evans KR, Farzan F, Foster JA, Frey BN, et al (2019). Symptomatic and Functional Outcomes and Early Prediction of Response to Escitalopram Monotherapy and Sequential Adjunctive Aripiprazole Therapy in Patients with Major Depressive Disorder: a CAN-BIND-1 Report. J Clin Psychiatry, 80(2). Abstract. Author URL.
Nogovitsyn N, Souza R, Muller M, Srajer A, Hassel S, Arnott SR, Davis AD, Hall GB, Harris JK, Zamyadi M, et al (2019). Testing a deep convolutional neural network for automated hippocampus segmentation in a longitudinal sample of healthy participants. Neuroimage, 197, 589-597. Abstract. Author URL.
Ismail Z, Gatchel J, Bateman DR, Barcelos-Ferreira R, Cantillon M, Jaeger J, Donovan NJ, Mortby ME (2018). Affective and emotional dysregulation as pre-dementia risk markers: exploring the mild behavioral impairment symptoms of depression, anxiety, irritability, and euphoria. Int Psychogeriatr, 30(2), 185-196. Abstract. Author URL.
Mallo SC, Ismail Z, Pereiro AX, Facal D, Lojo-Seoane C, Campos-Magdaleno M, Juncos-Rabadán O (2018). Assessing Mild Behavioral Impairment with the Mild Behavioral Impairment-Checklist in People with Mild Cognitive Impairment. J Alzheimers Dis, 66(1), 83-95. Abstract. Author URL.
Andrews SJ, Ismail Z, Anstey KJ, Mortby M (2018). Association of Alzheimer's genetic loci with mild behavioral impairment. Am J Med Genet B Neuropsychiatr Genet, 177(8), 727-735. Abstract. Author URL.
Cieslak A, Smith EE, Lysack J, Ismail Z (2018). Case series of mild behavioral impairment: toward an understanding of the early stages of neurodegenerative diseases affecting behavior and cognition. Int Psychogeriatr, 30(2), 273-280. Abstract. Author URL.
Mortby ME, Black SE, Gauthier S, Miller D, Porsteinsson A, Smith EE, Ismail Z (2018). Dementia clinical trial implications of mild behavioral impairment. Int Psychogeriatr, 30(2), 171-175. Abstract. Author URL.
Mele B, Holroyd-Leduc J, Smith EE, Pringsheim T, Ismail Z, Goodarzi Z (2018). Detecting anxiety in individuals with Parkinson disease: a systematic review. Neurology, 90(1), e39-e47. Abstract. Author URL.
Benedetti A, Wu Y, Levis B, Wilchesky M, Boruff J, Ioannidis JPA, Patten SB, Cuijpers P, Shrier I, Gilbody S, et al (2018). Diagnostic accuracy of the Geriatric Depression Scale-30, Geriatric Depression Scale-15, Geriatric Depression Scale-5 and Geriatric Depression Scale-4 for detecting major depression: protocol for a systematic review and individual participant data meta-analysis. BMJ Open, 8(12). Abstract. Author URL.
Ismail Z (2018). Dispensary cannabidiol marijuana and first-episode mania. J Psychiatry Neurosci, 43(3), 215-216. Author URL.
Qian W, Millikin C, Ismail Z, Smith EE, Munoz DG, Schweizer TA, Fischer CE (2018). F4‐03‐02: INCREASED ATROPHY IN THE DEFAULT MODE NETWORK IS ASSOCIATED WITH DEVELOPMENT OF DELUSIONS IN ALZHEIMER'S DISEASE. Alzheimer's & Dementia, 14(7S_Part_26), p1386-p1386.
Asmer MS, Kirkham J, Newton H, Ismail Z, Elbayoumi H, Leung RH, Seitz DP (2018). Meta-Analysis of the Prevalence of Major Depressive Disorder Among Older Adults with Dementia. J Clin Psychiatry, 79(5). Abstract. Author URL.
Black SAG, Templeton GW, Tsutsui S, Fischer K, Hernandez Y, Smith EE, Ismail Z, Stys PK (2018). P1‐275: AMIRASPEC: a BLOOD‐BASED DIAGNOSTIC FOR ALZHEIMER'S DISEASE USING SPECTRAL MICROSCOPY. Alzheimer's & Dementia, 14(7S_Part_7), p387-p388.
Monchi O, Ismail Z, Kibreab M, Yoon E, Kathol I, Hammer T, Cheetham J (2018). P1‐352: WHAT CAN THE MILD BEHAVIORAL IMPAIRMENT CHECKLIST (MBI‐C) TELL US ABOUT COGNITION AND BEHAVIOR IN PARKINSON'S DISEASE?. Alzheimer's & Dementia, 14(7S_Part_8), p429-p429.
Brooker H, Creese B, Ismail Z, Khan Z, Megalogeni M, Corbett A, Hampshire A, Aarsland D, Ballard C, Wesnes K, et al (2018). P1‐523: THE RELATIONSHIP BETWEEN THE MILD BEHAVIOURAL IMPAIRMENT CHECKLIST (MBI‐C) TOTAL SCORE AND CORE ASPECTS OF COGNITIVE FUNCTION IN OLDER ADULTS. Alzheimer's & Dementia, 14(7S_Part_9).
Kang Y, Chin J, Han N, Park J, Yeom J, Yang S-J, Ryu HJ, Lee BH, Yoo R, Ahn Y, et al (2018). P2‐292: MILD BEHAVIORAL IMPAIRMENT (MBI) IN MCI, SCD, AND NORMAL ELDERLY: a PILOT STUDY FOR VALIDATION OF THE MILD BEHAVIORAL IMPAIRMENT CHECKLIST (MBI‐C). Alzheimer's & Dementia, 14(7S_Part_15), p793-p793.
Ismail Z, Pham T, Smith EE, Patten SB, Atta C, Bulloch A, Fiest KM, Sajobi T, Wang M, Wiebe S, et al (2018). P2‐293: IS DEPRESSION REALLY DEPRESSION IN a MEMORY CLINIC? PREVALENCE, SCREENING AND DIAGNOSTIC ISSUES IN NEUROCOGNITIVE DISORDERS. Alzheimer's & Dementia, 14(7S_Part_15), p794-p794.
Ismail Z, Saykin AJ (2018). P3‐336: SUBJECTIVE COGNITIVE DECLINE (SCD) AND MILD BEHAVIORAL IMPAIRMENT (MBI): THE INTERSECTION OF TWO EARLY INDICATORS OF AD PATHOPHYSIOLOGY. Alzheimer's & Dementia, 14(7S_Part_23), p1210-p1211.
Creese B, Brooker H, Ismail Z, Aarsland D, Corbett A, Khan Z, Megalogeni M, Ballard C, Wesnes K (2018). P3‐554: PROFILE OF MILD BEHAVIOURAL IMPAIRMENT IN a POPULATION‐BASED SAMPLE OF ADULTS AGED 50 AND OVER: INITIAL FINDINGS FROM THE PROTECT STUDY. Alzheimer's & Dementia, 14(7S_Part_25).
Mallo SC, Pereiro AX, Ismail Z, Lojo-Seoane C, Campos-Magdaleno M, Facal D, Juncos-Rabadán O (2018). P4‐110: MILD BEHAVIORAL IMPAIRMENT CHECKLIST (MBI‐C): a PRELIMINARY VALIDATION STUDY. Alzheimer's & Dementia, 14(7S_Part_28), p1481-p1481.
Mortby ME, Ismail Z, Anstey KJ (2018). Prevalence estimates of mild behavioral impairment in a population-based sample of pre-dementia states and cognitively healthy older adults. Int Psychogeriatr, 30(2), 221-232. Abstract. Author URL.
Sheikh F, Ismail Z, Mortby ME, Barber P, Cieslak A, Fischer K, Granger R, Hogan DB, Mackie A, Maxwell CJ, et al (2018). Prevalence of mild behavioral impairment in mild cognitive impairment and subjective cognitive decline, and its association with caregiver burden. Int Psychogeriatr, 30(2), 233-244. Abstract. Author URL.
Mortby ME, Lyketsos CG, Geda YE, Ismail Z (2018). Special Issue on mild behavioral impairment and non-cognitive prodromes to dementia. Int Psychogeriatr, 30(2), 167-169. Abstract. Author URL.
Goodarzi Z, Ismail Z (2017). A practical approach to detection and treatment of depression in Parkinson disease and dementia. Neurol Clin Pract, 7(2), 128-140. Abstract. Author URL.
Andrews SJ, Ismail Z, Anstey KJ, Mortby M (2017). Alzheimer’s Genetic Risk Score linked to Incident Mild Behavioral Impairment. Abstract.
Lanctôt KL, Agüera-Ortiz L, Brodaty H, Francis PT, Geda YE, Ismail Z, Marshall GA, Mortby ME, Onyike CU, Padala PR, et al (2017). Apathy associated with neurocognitive disorders: Recent progress and future directions. Alzheimer's and Dementia, 13(1), 84-100. Abstract.
Ismail Z, Peters-Strickland T, Miguelez M, Baker RA, Hertel P, Eramo A, Jin N, Perry P, Sanchez R, McQuade RD, et al (2017). Aripiprazole Once-Monthly in the Treatment of Acute Psychotic Episodes in Schizophrenia: Post Hoc Analysis of Positive and Negative Syndrome Scale Marder Factor Scores. J Clin Psychopharmacol, 37(3), 347-350. Abstract. Author URL.
Addington D, Abidi S, Garcia-Ortega I, Honer WG, Ismail Z (2017). Canadian Guidelines for the Assessment and Diagnosis of Patients with Schizophrenia Spectrum and Other Psychotic Disorders. Can J Psychiatry, 62(9), 594-603. Abstract. Author URL.
Fischer CE, Qian W, Schweizer TA, Ismail Z, Smith EE, Millikin CP, Munoz DG (2017). Determining the impact of psychosis on rates of false-positive and false-negative diagnosis in Alzheimer's disease. Alzheimers Dement (N Y), 3(3), 385-392. Abstract. Author URL.
Remington G, Addington D, Honer W, Ismail Z, Raedler T, Teehan M (2017). Guidelines for the Pharmacotherapy of Schizophrenia in Adults. Can J Psychiatry, 62(9), 604-616. Abstract. Author URL.
Mortby ME, Burns R, Eramudugolla R, Ismail Z, Anstey KJ (2017). Neuropsychiatric Symptoms and Cognitive Impairment: Understanding the Importance of Co-Morbid Symptoms. J Alzheimers Dis, 59(1), 141-153. Abstract. Author URL.
Lanctôt KL, Amatniek J, Ancoli-Israel S, Arnold SE, Ballard C, Cohen-Mansfield J, Ismail Z, Lyketsos C, Miller DS, Musiek E, et al (2017). Neuropsychiatric signs and symptoms of Alzheimer's disease: New treatment paradigms. Alzheimer's and Dementia: Translational Research and Clinical Interventions, 3(3), 440-449. Abstract.
Pringsheim T, Kelly M, Urness D, Teehan M, Ismail Z, Gardner D (2017). Physical Health and Drug Safety in Individuals with Schizophrenia. Can J Psychiatry, 62(9), 673-683. Abstract. Author URL.
Asmer MS, Kirkham J, Newton HT, Ismail Z, Leung R, Elbayoumi H, Seitz D (2017). Poster Number: EI 11 Systematic Review and Meta-Analysis of the Prevalence of Major Depressive Disorder among Older Adults with Alzheimer's Disease and Related Forms of Dementia. American Journal of Geriatric Psychiatry, 25(3), s73-s74.
Ismail Z, Elbayoumi H, Fischer CE, Hogan DB, Millikin CP, Schweizer T, Mortby ME, Smith EE, Patten SB, Fiest KM, et al (2017). Prevalence of Depression in Patients with Mild Cognitive Impairment: a Systematic Review and Meta-analysis. JAMA Psychiatry, 74(1), 58-67. Abstract. Author URL.
Lam RW, Ismail Z, MacQueen GM, Milev RV, Parikh SV, Ravindran AV, Kennedy SH (2017). Response to Letter Regarding CANMAT Recommendations for the Pharmacological Treatment of Late-life Depression. Can J Psychiatry, 62(5), 353-354. Author URL.
Ismail Z, Rajji TK, Kumar S, Burhan A (2017). Session 408 Recent Advances in Prevention, Diagnosis and Management of Dementia and the Associated Neuropsychiatric Symptoms. American Journal of Geriatric Psychiatry, 25(3).
Ismail Z, Agüera-Ortiz L, Brodaty H, Cieslak A, Cummings J, Fischer CE, Gauthier S, Geda YE, Herrmann N, Kanji J, et al (2017). The Mild Behavioral Impairment Checklist (MBI-C): a Rating Scale for Neuropsychiatric Symptoms in Pre-Dementia Populations. J Alzheimers Dis, 56(3), 929-938. Abstract. Author URL.
Smith EE, Cieslak A, Barber P, Chen J, Chen Y-W, Donnini I, Edwards JD, Frayne R, Field TS, Hegedus J, et al (2017). Therapeutic Strategies and Drug Development for Vascular Cognitive Impairment. J Am Heart Assoc, 6(5). Author URL.
Aguera-Ortiz LF, Lopez-Alvarez J, Del Nido-Varo L, Soria Garcia-Rosel E, Perez-Martinez DA, Ismail Z (2017). [Mild behavioural impairment as an antecedent of dementia: presentation of the diagnostic criteria and the Spanish version of the MBI-C scale for its evaluation]. Rev Neurol, 65(7), 327-334. Abstract. Author URL.
Andrews SJ, Mortby ME, Ismail Z, Anstey KJ (2017). [P1–140]: ALZHEIMER's GENETIC RISK SCORE LINKED TO MILD BEHAVIORAL IMPAIRMENT. Alzheimer's & Dementia, 13(7S_Part_6), p296-p296.
Mallo SC, Pereiro AX, Facal D, Lojo‐Seoane C, Campos‐Magdaleno M, Ismail Z, Juncos‐Rabadán O (2017). [P1–296]: ASSESSING MILD BEHAVIORAL IMPAIRMENT IN PEOPLE WITH SUBJECTIVE COGNITIVE COMPLAINTS (SCCS) WITH THE MILD BEHAVIORAL IMPAIRMENT CHECKLIST (MBI‐C): a PILOT STUDY. Alzheimer's & Dementia, 13(7S_Part_7), p364-p365.
Mortby ME, Eramudugolla R, Burns R, Ismail Z, Anstey KJ (2017). [P2–274]: MILD BEHAVIORAL IMPAIRMENT: WHAT ARE THE RISK FACTORS?. Alzheimer's & Dementia, 13(7S_Part_14), p719-p719.
Beaudin A, Cieslak A, Zerna C, Barber P, Black SE, Frayne R, Field TS, Hachinski V, Ismail Z, Sharma M, et al (2017). [P3–012]: OUTCOMES IN VASCULAR DEMENTIA TRIAL PATIENTS: a META‐ANALYSIS OF PLACEBO DATA FROM PRIOR RANDOMIZED CONTROLLED TRIALS. Alzheimer's & Dementia, 13(7S_Part_19), p933-p934.
Brown EE, Graff-Guerrero A, Houle S, Mizrahi R, Wilson AA, Pollock BG, Mulsant BH, Felsky D, Voineskos AN, Tang-Wai DF, et al (2016). Amyloid deposition in semantic dementia: a positron emission tomography study. Int J Geriatr Psychiatry, 31(9), 1064-1074. Abstract. Author URL.
Fischer CE, Golas AC, Schweizer TA, Munoz DG, Ismail Z, Qian W, Tang-Wai DF, Rotstein DL, Day GS (2016). Anti N-methyl-D-aspartate receptor encephalitis: a game-changer?. Expert Rev Neurother, 16(7), 849-859. Abstract. Author URL.
(2016). Canadian Academy of Geriatric Psychiatry 2015 Annual Scientific Meeting Abstracts. Canadian geriatrics journal : CGJ, 19(1), 1-14. Abstract.
MacQueen GM, Frey BN, Ismail Z, Jaworska N, Steiner M, Lieshout RJV, Kennedy SH, Lam RW, Milev RV, Parikh SV, et al (2016). Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 6. Special Populations: Youth, Women, and the Elderly. Can J Psychiatry, 61(9), 588-603. Abstract. Author URL.
Case NF, Charlton A, Zwiers A, Batool S, McCreary CR, Hogan DB, Ismail Z, Zerna C, Coutts SB, Frayne R, et al (2016). Cerebral Amyloid Angiopathy is Associated with Executive Dysfunction and Mild Cognitive Impairment. Stroke, 47(8), 2010-2016. Abstract. Author URL.
Thombs BD, Benedetti A, Kloda LA, Levis B, Azar M, Riehm KE, Saadat N, Cuijpers P, Gilbody S, Ioannidis JPA, et al (2016). Diagnostic accuracy of the Depression subscale of the Hospital Anxiety and Depression Scale (HADS-D) for detecting major depression: protocol for a systematic review and individual patient data meta-analyses. BMJ Open, 6(4). Abstract. Author URL.
Lam RW, Milev R, Rotzinger S, Andreazza AC, Blier P, Brenner C, Daskalakis ZJ, Dharsee M, Downar J, Evans KR, et al (2016). Discovering biomarkers for antidepressant response: protocol from the Canadian biomarker integration network in depression (CAN-BIND) and clinical characteristics of the first patient cohort. BMC Psychiatry, 16 Abstract. Author URL.
Fischer CE, Ting WK-C, Millikin CP, Ismail Z, Schweizer TA, Alzheimer Disease Neuroimaging Initiative (2016). Gray matter atrophy in patients with mild cognitive impairment/Alzheimer's disease over the course of developing delusions. Int J Geriatr Psychiatry, 31(1), 76-82. Abstract. Author URL.
Fischer CE, Qian W, Schweizer TA, Millikin CP, Ismail Z, Smith EE, Lix LM, Shelton P, Munoz DG (2016). Lewy Bodies, Vascular Risk Factors, and Subcortical Arteriosclerotic Leukoencephalopathy, but not Alzheimer Pathology, are Associated with Development of Psychosis in Alzheimer's Disease. J Alzheimers Dis, 50(1), 283-295. Abstract. Author URL.
Ismail Z, Smith EE, Geda Y, Sultzer D, Brodaty H, Smith G, Agüera-Ortiz L, Sweet R, Miller D, Lyketsos CG, et al (2016). Neuropsychiatric symptoms as early manifestations of emergent dementia: Provisional diagnostic criteria for mild behavioral impairment. Alzheimers Dement, 12(2), 195-202. Abstract. Author URL.
Tsutsui S, Roychoudhury S, Ota T, Jones MR, Ismail Z, Cieslak A, Poulin MJ, Barber P, Smith EE, Stys PK, et al (2016). O1‐05‐05: Detection of Early Alzheimer’s Disease from Blood Using Novel Microspectroscopy. Alzheimer's & Dementia, 12(7S_Part_4), p184-p185.
Ismail Z, Brodaty H, Cieslak A, Fischer CE, Gauthier S, Geda YE, Herrmann N, Kanji J, Lanctot KL, Miller D, et al (2016). O1‐13‐03: the Mild Behavioral Impairment Checklist (MBI‐C): a New Rating Scale for Neuropsychiatric Symptoms as Early Manifestations of Neurodegenerative Disease. Alzheimer's & Dementia, 12(7S_Part_4), p209-p210.
Cieslak A, Barber P, Black SE, Chen J, Edwards JD, Elbayoumi H, Frayne R, Field TS, Hachinski V, Hegedus J, et al (2016). P2‐027: Systematic Review of RCTS of Interventions for Vascular Cognitive Impairment. Alzheimer's & Dementia, 12(7S_Part_12), p619-p619.
Ismail Z, Barber P, Cieslak A, Fischer K, Granger R, Hogan DB, Jones H, Mackie A, Maxwell CJ, Menon B, et al (2016). P2‐176: Prevalence of Mild Behavioral Impairment (MBI) in a Memory Clinic Population and the Impact on Caregiver Burden. Alzheimer's & Dementia, 12(7S_Part_14), p683-p684.
Rosenberg PB, Drye LT, Porsteinsson AP, Pollock BG, Devanand DP, Frangakis C, Ismail Z, Marano C, Meinert CL, Mintzer JE, et al (2015). Change in agitation in Alzheimer's disease in the placebo arm of a nine-week controlled trial. Int Psychogeriatr, 27(12), 2059-2067. Abstract. Author URL.
Ismail Z (2015). F5‐05‐04: Mild behavioral impairment (MBI): Background, description of the construct, and criteria development. Alzheimer's & Dementia, 11(7S_Part_7), p310-p311.
Ting WK-C, Fischer CE, Millikin CP, Ismail Z, Chow TW, Schweizer TA (2015). Grey matter atrophy in mild cognitive impairment / early Alzheimer disease associated with delusions: a voxel-based morphometry study. Curr Alzheimer Res, 12(2), 165-172. Abstract. Author URL.
Fischer C, Qian W, Schweizer T, Millikin C, Ismail Z, Smith E, Lix L, Shelton P, Munoz D, Johnston A, et al (2015). Oral Abstract Presentations at the 8th Canadian Conference on Dementia (CCD), Ottawa, October 2015. Canadian geriatrics journal : CGJ, 18(4), 246-249. Abstract.
Ismail Z, Elbayoumi H, Fischer CE, Hogan D, Millikin C, Schweizer T, Smith EE, Patten S, Fiest KM (2015). P2‐087: a systematic review and meta‐analysis for the prevalence of depression in mild cognitive impairment. Alzheimer's & Dementia, 11(7S_Part_11), p516-p517.
Ismail Z, Arenovich T, Grieve C, Willett P, Addington D, Rajji TK, Mulsant BH (2015). Predicting hospital length of stay for geriatric and adult patients with schizophrenia. Journal of Hospital Administration, 4(2).
Weintraub D, Drye LT, Porsteinsson AP, Rosenberg PB, Pollock BG, Devanand DP, Frangakis C, Ismail Z, Marano C, Meinert CL, et al (2015). Time to Response to Citalopram Treatment for Agitation in Alzheimer Disease. Am J Geriatr Psychiatry, 23(11), 1127-1133. Abstract. Author URL.
Mulsant BH, Blumberger DM, Ismail Z, Rabheru K, Rapoport MJ (2014). A systematic approach to pharmacotherapy for geriatric major depression. Clin Geriatr Med, 30(3), 517-534. Abstract. Author URL.
Ismail Z, Arenovich T, Granger R, Grieve C, Willett P, Patten S, Mulsant BH (2014). Associations of medical comorbidity, psychosis, pain, and capacity with psychiatric hospital length of stay in geriatric inpatients with and without dementia. Int Psychogeriatr, 1-9. Abstract. Author URL.
Jalal H, Ganesh A, Lau R, Lysack J, Ismail Z (2014). Cholinesterase-inhibitor Associated Mania: a Case Report and Literature Review. Can J Neurol Sci, 41(2), 278-280. Author URL.
Ismail Z, Malick A, Smith EE, Schweizer T, Fischer C (2014). Depression versus dementia: is this construct still relevant?. Neurodegener Dis Manag, 4(2), 119-126. Abstract. Author URL.
Porsteinsson AP, Drye LT, Pollock BG, Devanand DP, Frangakis C, Ismail Z, Marano C, Meinert CL, Mintzer JE, Munro CA, et al (2014). Effect of citalopram on agitation in Alzheimer disease: the CitAD randomized clinical trial. JAMA, 311(7), 682-691. Abstract. Author URL.
Ismail Z, Fischer C (2014). Emerging concepts in geriatric psychiatry: an update on the canadian academy of geriatric psychiatry annual scientific meeting. Can Geriatr J, 17(1), 2-4. Author URL.
Egeto P, Fischer CE, Ismail Z, Smith EE, Schweizer TA (2014). Lacunar stroke, deep white matter disease and depression: a meta-analysis. Int Psychogeriatr, 26(7), 1101-1109. Abstract. Author URL.
(2014). The Canadian Coalition for Seniors' Mental Health (CCSMH) and Canadian Academy of Geriatric Psychiatry (CAGP) Joint Scientific Meeting. Can Geriatr J, 17(4), 165-201. Author URL.
Ismail Z, Emeremni CA, Houck PR, Mazumdar S, Rosen J, Rajji TK, Pollock BG, Mulsant BH (2013). A comparison of the E-BEHAVE-AD, NBRS, and NPI in quantifying clinical improvement in the treatment of agitation and psychosis associated with dementia. Am J Geriatr Psychiatry, 21(1), 78-87. Abstract. Author URL.
Wilchesky M, McCusker J, Cole MG, Voyer P, Champoux N, Monette J, Vu M, Ciampi A, Belzile E, Ting W, et al (2013). Abstracts from the 7th Canadian Conference on Dementia (CCD) held in Vancouver, October 2013. Canadian geriatrics journal : CGJ, 16(4), 196-199. Abstract.
Blumberger D, Lespérance P, Aminzadeh F, Byszewski A, Lee L, Burhan AM, Borrie M, Rosa-Neto P, Soucy JP, Mulsant B, et al (2013). Canadian Academy of Geriatric Psychiatry 2013 Annual Scientific Meeting Abstracts. Canadian geriatrics journal : CGJ, 17(1), 27-36. Abstract.
Ismail Z, Mulsant BH, Herrmann N, Rapoport M, Nilsson M, Shulman K (2013). Canadian academy of geriatric psychiatry survey of brief cognitive screening instruments. Can Geriatr J, 16(2), 54-60. Abstract. Author URL.
Rajji TK, Voineskos AN, Butters MA, Miranda D, Arenovich T, Menon M, Ismail Z, Kern RS, Mulsant BH (2013). Cognitive performance of individuals with schizophrenia across seven decades: a study using the MATRICS consensus cognitive battery. Am J Geriatr Psychiatry, 21(2), 108-118. Abstract. Author URL.
Suzuki T, Graff-Guerrero A, Uchida H, Remington G, Caravaggio F, Borlido C, Pollock B, Mulsant B, Deluca V, Ismail Z, et al (2013). Dopamine D₂/₃ occupancy of ziprasidone across a day: a within-subject PET study. Psychopharmacology (Berl), 228(1), 43-51. Abstract. Author URL.
Fischer CE, Ismail Z, Rapoport MJ (2013). Geriatric Psychiatry or Psychogeriatrics? Partnership at the CAGP/CCSMH 2012 Scientific Meeting. Can Geriatr J, 16(1), 3-5. Author URL.
Ismail Z, Fischer C, McCall WV (2013). What characterizes late-life depression?. Psychiatr Clin North Am, 36(4), 483-496. Abstract. Author URL.
Ismail Z, Emeremni CA, Houck PR, Mazumdar S, Rosen J, Rajji TK, Pollock BG, Mulsant BH (2012). A Comparison of the E-BEHAVE-AD, NBRS, and NPI in Quantifying Clinical Improvement in the Treatment of Agitation and Psychosis Associated with Dementia. American Journal of Geriatric Psychiatry
Ismail Z, Wessels AM, Uchida H, Ng W, Mamo DC, Rajji TK, Pollock BG, Mulsant BH, Bies RR (2012). Age and sex impact clozapine plasma concentrations in inpatients and outpatients with schizophrenia. Am J Geriatr Psychiatry, 20(1), 53-60. Abstract. Author URL.
Rajji TK, Chow TW, Voineskos AN, Links KA, Miranda D, Mamo DC, Ismail Z, Pollock BG, Mulsant BH (2012). Cholinergic pathways and cognition in patients with schizophrenia: a pilot study. Schizophr Res, 139(1-3), 46-52. Abstract. Author URL.
Drye LT, Ismail Z, Porsteinsson AP, Rosenberg PB, Weintraub D, Marano C, Pelton G, Frangakis C, Rabins PV, Munro CA, et al (2012). Citalopram for agitation in Alzheimer's disease: design and methods. Alzheimers Dement, 8(2), 121-130. Abstract. Author URL.
Rajji TK, Voineskos AN, Butters MA, Miranda D, Arenovich T, Menon M, Ismail Z, Kern RS, Mulsant BH (2012). Cognitive Performance of Individuals with Schizophrenia Across Seven Decades. American Journal of Geriatric Psychiatry
Addington D, McKenzie E, Smith H, Chuang H, Boucher S, Adams B, Ismail Z (2012). Conformance to evidence-based treatment recommendations in schizophrenia treatment services. Can J Psychiatry, 57(5), 317-323. Abstract. Author URL.
Fischer CE, Ismail Z, Schweizer TA (2012). Delusions increase functional impairment in Alzheimer's disease. Dement Geriatr Cogn Disord, 33(6), 393-399. Abstract. Author URL.
Addington DE, Mckenzie E, Wang J, Smith HP, Adams B, Ismail Z (2012). Development of a core set of performance measures for evaluating schizophrenia treatment services. Psychiatr Serv, 63(6), 584-591. Abstract. Author URL.
Fischer CE, Ismail Z, Schweizer TA (2012). Impact of neuropsychiatric symptoms on caregiver burden in patients with Alzheimers disease. Neurodegenerative Disease Management, 2(3), 269-277.
Ismail Z, Nguyen M-Q, Fischer CE, Schweizer TA, Mulsant BH (2012). Neuroimaging of delusions in Alzheimer's disease. Psychiatry Res, 202(2), 89-95. Abstract. Author URL.
Ismail Z, Arenovich T, Grieve C, Willett P, Sajeev G, Mamo DC, MacQueen GM, Mulsant BH (2012). Predicting Hospital Length of Stay for Geriatric Patients with Mood Disorders. The Canadian Journal of Psychiatry, 57(10), 627-634.
Ismail Z, Arenovich T, Grieve C, Willett P, Sajeev G, Mamo DC, Macqueen GM, Mulsant BH (2012). Predicting hospital length of stay for geriatric patients with mood disorders. Can J Psychiatry, 57(11), 696-703. Abstract. Author URL.
Ismail Z, Nguyen M-Q, Fischer CE, Schweizer TA, Mulsant BH, Mamo D (2011). Neurobiology of delusions in Alzheimer's disease. Curr Psychiatry Rep, 13(3), 211-218. Abstract. Author URL.
Ismail Z, Rajji TK, Shulman KI (2010). Brief cognitive screening instruments: an update. Int J Geriatr Psychiatry, 25(2), 111-120. Abstract. Author URL.
Rajji TK, Uchida H, Ismail Z, Ng W, Mamo DC, Remington G, Pollock BG, Mulsant BH (2010). Clozapine and global cognition in schizophrenia. J Clin Psychopharmacol, 30(4), 431-436. Abstract. Author URL.
Ting C, Rajji TK, Ismail Z, Tang-Wai DF, Apanasiewicz N, Miranda D, Mamo D, Mulsant BH (2010). Differentiating the cognitive profile of schizophrenia from that of Alzheimer disease and depression in late life. PLoS One, 5(4). Abstract. Author URL.
Iracleous P, Nie JX, Tracy CS, Moineddin R, Ismail Z, Shulman KI, Upshur REG (2010). Primary care physicians' attitudes towards cognitive screening: findings from a national postal survey. Int J Geriatr Psychiatry, 25(1), 23-29. Abstract. Author URL.
Ismail Z, Syms J, Blumberger D, George TP (2010). Varenicline induced polydipsia and hyponatremia in a patient with schizophrenia. Schizophr Res, 119(1-3). Author URL.
Ismail Z, Herrmann N, Francis PL, Rothenburg LS, Lobaugh NJ, Leibovitch FS, Black SE, Lanctôt KL (2009). A SPECT study of sleep disturbance and Alzheimer's disease. Dement Geriatr Cogn Disord, 27(3), 254-259. Abstract. Author URL.
Rajji TK, Ismail Z, Mulsant BH (2009). Age at onset and cognition in schizophrenia: meta-analysis. Br J Psychiatry, 195(4), 286-293. Abstract. Author URL.
Ng W, Uchida H, Ismail Z, Mamo DC, Rajji TK, Remington G, Sproule B, Pollock BG, Mulsant BH, Bies RR, et al (2009). Clozapine exposure and the impact of smoking and gender: a population pharmacokinetic study. Ther Drug Monit, 31(3), 360-366. Abstract. Author URL.
Thakore S, Ismail Z, Jarvis S, Payne E, Keetbaas S, Payne R, Rothenburg L (2009). The perceptions and habits of alcohol consumption and smoking among Canadian medical students. Acad Psychiatry, 33(3), 193-197. Abstract. Author URL.
Ismail Z, Herrmann N, Rothenburg LS, Cotter A, Leibovitch FS, Rafi-Tari S, Black SE, Lanctôt KL (2008). A functional neuroimaging study of appetite loss in Alzheimer's disease. J Neurol Sci, 271(1-2), 97-103. Abstract. Author URL.
Ismail Z, el-Guebaly N (1998). Nicotine and endogenous opioids: toward specific pharmacotherapy. Can J Psychiatry, 43(1), 37-42. Abstract. Author URL.
Chapters
Mortby M, Mele B, Ismail Z, Miller D (2021). Measurement of Apathy. In (Ed) Apathy, Oxford University Press (OUP), 19-38.
Ismail Z, Mortby ME (2017). Cognitive and Neuropsychiatric Screening Tests in Older Adults. In (Ed) Mental Health and Illness of the Elderly, Springer Nature, 1-26.
Ismail Z, Mortby ME (2017). Cognitive and Neuropsychiatric Screening Tests in Older Adults. In (Ed) Mental Health and Illness of the Elderly, Springer Nature, 343-368.
Ismail Z, Granger R, Pollock BG (2015). General Principles of Pharmacologic Therapy. In (Ed) Psychiatry, Wiley, 2025-2040.
Ismail Z, Pollock BG, Roose SP (2008). General Principles of Pharmacologic Therapy. In (Ed) Psychiatry: Third Edition, 2097-2111. Abstract.
Conferences
Guseva E, Iaboni A, Herrmann N, Ismail Z, Lanctot K, Seitz D, Burhan A, Wilchesky M (2023). ASSOCIATION BETWEEN MOTOR ACTIVITY AND TOTAL NEUROPSYCHIATRIC INVENTORY NURSING HOME VERSION SCORES. Author URL.
Tumati S, Boyd E, Ismail Z, Mah E, Seitz D, Herrmann N, Lanctot K (2023). NEUROPSYCHIATRIC SYMPTOMS AND THEIR RELATIONSHIP WITH WHITE MATTER HYPERINTENSITIES IN MILD VASCULAR COGNITIVE IMPAIRMENT, MILD COGNITIVE IMPAIRMENT, ALZHEIMER'S DISEASE AND MIXED DEMENTIA - a COMPASS-ND STUDY. Author URL.
Ismail Z, Pedersen A, Thase ME, Meehan SR, Weiss C, Larsen KG, Chen D, Nylander AG, Baker RA, McIntyre RS, et al (2020). A post-hoc analysis of the effect of brexpiprazole on patient engagement in patients with schizophrenia. Author URL.
Ramezani M, Ruskey J, Martens K, Leveille E, Javer Z, Kathol I, Kibreab M, Hammer T, Cheetham J, Sarna J, et al (2020). Association between BDNF Val66Met polymorphism and mild behavioral impairment in patients with Parkinson's patients. Author URL.
Smith EE, Barber P, Field TS, Ganesh A, Hachinski V, Hogan DB, Lanctôt KL, Lindsay MP, Sharma M, Swartz RH, et al (2020). Canadian Consensus Conference on Diagnosis and Treatment of Dementia (CCCDTD)5: Guidelines for management of vascular cognitive impairment. Abstract.
Showraki A, Murari G, Ismail Z, Barfett J, Munoz D, Schweizer T, Fornazzari L, Fischer C (2019). CEREBROSPINAL FLUID CORRELATES OF NEUROPSYCHIATRIC SYMPTOMS IN PATIENTS WITH ALZHEIMER'S DISEASE/MILD COGNITIVE IMPAIRMENT. Author URL.
Suh JS, Minuzzi L, Raamana P, Strother SC, MacQueen GM, Hassel S, Alders G, Arnott S, Davis AD, Harris JK, et al (2019). Cortical Thickness Features Differentiate 16-Week Antidepressant Response Profiles in Major Depressive Disorder. Author URL.
Gill S, Wang M, Forkert ND, MacMaster FP, Smith EE, Ismail Z (2019). Diffusion Tensor Imaging in Predementia Risk States: White Matter Integrity Findings in Mild Behavioral Impairment. Author URL.
Gill S, Wang M, Forkert ND, MacMaster FP, Smith EE, Ismail Z (2019). Diffusion Tensor Imaging in pre-dementia risk states: white matter atrophly findings in Mild Behavioral Impairment. Author URL.
Desjardins C, Nogovitsyn N, Souza R, Hassel S, Arnott S, Davis AD, Hall GB, Harris JK, Zamyadi M, Metzak PD, et al (2019). Hippocampal Subfield-Specific Sex Differences in Patients with Major Depressive Disorder. Author URL.
Lussier FZ, Pascoal TA, Therriault J, Chamoun M, Tissot C, Savard M, Mathotaarachchi S, Ismail Z, Rosa-Neto P, Gauthier S, et al (2019). Mild behavioral impairment is associated with β-amyloid and tau across the alzheimer's disease spectrum. Author URL.
Yoon EJ, Ismail Z, Kibreab M, Hammer T, Cheetham J, Kathol I, Ramezani M, Lang S, Sarna J, Martino D, et al (2019). Patterns of brain activity linked to Mild Behavioral Impairment in Parkinson's disease. Author URL.
Hu S, Patten S, Fick G, Smith E, Ismail Z (2019). Predictive Utility of the Mild Behavioral Impairment Checklist in Subjective Cognitive Decline, Mild Cognitive Impairment, and Dementia. Author URL.
Nogovitsyn N, Srajer A, Muller M, Metzak P, Hassel S, Souza R, Bray S, Lebel C, Goldstein B, Kennedy S, et al (2019). Subfield-Specific Hippocampal Volumes in Youth at Risk for Mental Illness. Author URL.
Ismail Z (2017). Cognitive and Neuropsychiatric Screening for Early Dementia Detection. Author URL.
Ismail Z, Rajji TK, Kumar S, Burhan A (2017). RECENT ADVANCES IN PREVENTION, DIAGNOSIS AND MANAGEMENT OF DEMENTIA AND THE ASSOCIATED NEUROPSYCHIATRIC SYMPTOMS. Author URL.
Asmer MS, Kirkham J, Newton HT, Ismail Z, Leung R, Elbayoumi H, Seitz D (2017). Systematic Review and Meta-Analysis of the Prevalence of Major Depressive Disorder among Older Adults with Alzheimer's Disease and Related Forms of Dementia. Author URL.
Millikin C, Stoesz BM, Ismail Z, Fischer CE, Schweizer T (2014). Factors Associated with Development and Stability of Delusions in Probable Alzheimer's Disease. Author URL.
Fischer CE, Ting WK, Millikin C, Ismail Z, Schweizer T (2014). Grey Matter Atrophy Associated with Delusional Onset in Mild Cognitive Impairment Patients. Author URL.
Brown EE, Graff-Guerrero A, Houle S, Wilson A, Ismail Z, Pollock BG, Mulsant BH, Tang-Wai DF, Verhoeff NP, Freedman M, et al (2014). PIB-Positive PET in Individuals with Early- but Not Late-Onset Frontotemporal Dementia. Author URL.
Fischer C, Sweet RA, Ismail Z (2013). FITTING a SQUARE PEG INTO a ROUND HOLE: UNDERSTANDING PSYCHOTIC SYMPTOMS IN ALZHEIMER'S DISEASE. Author URL.
Hinton L, Hargrave R, Ismail Z, Ahmed I (2012). ENHANCING CULTURALLY COMPETENT MENTAL HEALTH CARE FOR OLDER ADULTS: OVERVIEW AND APPLICATION OF THE DSM CULTURAL FORMULATION. Author URL.
Fischer CE, Forrest L, Ismail Z, Joy J, Schweizer TA (2011). Delusions, Frontal Lobe and Real World Functioning in Alzheimer's. Author URL.
Rajji T, Uchida H, Ismail Z, Ng W, Mamo D, Remington G, Pollock BG, Mulsant BH (2010). Clozapine and Global Cognition in Schizophrenia. Author URL.
Ismail Z, Harvey P, Palmer B, Jeste D (2008). COGNITION AND FUNCTION IN LATE-LIFE SCHIZOPHRENIA. Author URL.
Ismail Z, Herrmann N, Francis P, Rothenburg L, Lobaugh N, Leibovitch F, Black S, Lanctot K (2008). Sleep Disturbance and Alzheimer's Disease. Author URL.
Ismail Z, Herrmann N, Rothenburg L, Cotter A, Leibovitch F, Rafi-Tari S, Lanctot K, Black S (2007). A functional neuroimaging study of appetite loss in Alzheimer's disease. Author URL.
McKenzie E, Chuang H, Smith H, Ismail Z, Boucher S, Addington D (2005). Conformance to quality standards in schizophrenia services. Author URL.
